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Chapter 1 
The biological barriers with their specific permeability limit and control 
the access of exogenous molecules to the interior of cells and the 
translocation across the adsorbing epithelia. Researchers and patients 
would benefit from efficient methods for intracellular delivery of a wide 
range of molecules (biochemically active small molecules, imaging 
agents, peptides, nucleic acids, proteins, drugs and micronutrients). A 
deep knowledge of the mechanisms underlying nanomaterial 
interactions with membrane and the comprehension of the effects on the 
cellular physiology is required, to avoid off-target adverse effects and 
to boost the use of these potentially revolutionary compounds in 
nanomedicine. 
Nanotechnology and Nanomaterials 
Nanoscience is the study of matter at the atomic and molecular scale, 
roughly in the 0.1-1000 nm range. From the visionary ideas of Richard 
Feynman (Nobel Prize in Physics in 1965), expressed in his speech 
“There’s Plenty of Room at the Bottom” held at the American Physical 
Society in 1959(1S), the study of the smallest component of matter has 
gained the status of an independent, yet integrated, discipline, which is 
nowadays called nanotechnology, as it was baptised from Norio 
Taniguchi in 1974(2S). According to the European Union’s Scientific 
Committee on Emerging and Newly Identified Health Risks, 
nanotechnology is defined as “those areas of science and engineering 
where phenomena that take place at dimensions in the nanometre 
scale are utilised in the design, characterisation, production and 
application of materials, structures, devices and systems”(3S). 
Nanomaterials (NMs) are defined as are materials that have at least one 
dimension in the range of 1–100 nm; it is possible to recognize materials 
with 1 dimension in this range (nanofilms, nanosheets), with 2 
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dimensions in this range (nanotubes, nanowires) and with 3 dimensions 
in this range (nanoparticles). One of the nanotechnology purposes is to 
create new products with properties and functions that differ from the 
corresponding bulk materials. Superior properties of NMs in terms of 
chemical reactivity, electrical resistance/conductivity and biological 
activity can be ascribed to the increased surface area to volume ratio; 
moreover, their dimensional range allows direct interactions with 
biomolecules of interest, increasing the biological relevance of NMs. 
 
Figure 1: Logarithmical length scale showing size of nanomaterials compared 
to biological components and definition of “nano” and “micro” ranges[1] 
NMs are now widespread in different fields[2-5], spacing from industrial 
application, such as catalyst[6, 7]], [341], cosmetics[8-11], photovoltaic 
devices[342], to electronics[12], agriculture[13, 14], food safety[15-17], as well as 
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emerging every day more in the biomedical field as sensors[18-22], 
imaging tools[23-25], drug delivery agents[26-35] or as direct therapeutic 
agents[36, 37]. 
Nanoparticles 
Among NMs, nanoparticles (NPs) are the ones attracting more and 
more interest, in areas such as biology and medicine, as well as there is 
concern for their possible effect on health and environment.  
It is possible to classify NPs from their origin, distinguishing between 
natural and anthropogenic NPs (Table 1). Anthropogenic NPs can be 
further divided in unintentional and intentional, with the first coming 
from different processes as byproducts and the latter synthesized with 
high monodispersity and precise chemical composition[38].  
Tab. 1: the main sources of nanoparticles[1, 38] 
 
A lot of other features can be used to identify and classify NPs, such as 
composition, size, shape, superficial charge, and many others, that can 
modulate the NP interactions with the biological world[4, 26, 39-41]. 
Composition and structure 
Four categories of NPs can be identified based on their composition[42]: 
 Carbon-based: carbon is the main element constituting these 
NPs, being responsible for their peculiar chemical properties 
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and shapes (i.e hollow tubes, ellipsoids or spheres). Fullerenes, 
carbon nanotubes, carbon nanofibers, carbon black, graphene, 
and carbon onions are included under the carbon-based NMs 
category. 
 Inorganic: these NPs include metal and metal oxide, like Au, Ag, 
TiO2 and ZnO, and semiconductors such as silicon and ceramics. 
 Organic-based: organic matter is the base for these NPs, from 
which are excluded carbon-based NPs since carbon in these NPs 
is just a part of a more complex and biologically inspired 
architecture. The utilization of noncovalent interactions for the 
design of molecules helps to transform the organic NMs into 
structures like dendrimers, micelles, liposomes and polymeric 
NPs. 
 Composite-based: multiphase NPs with one phase on the 
nanoscale dimension that can either combine NPs with other 
NPs or NPs combined with larger or with bulk-type materials 
(e.g., hybrid nanofibers) or more complicated structures, such as 
a metalorganic framework. The composites may be any 
combinations of carbon-based, metal-based, or organic-based 
NPs with any form of metal, ceramic, or polymer bulk materials. 
Size  
NP size and surface area play a major role as determinants of the NP 
interaction with living systems[43-45]. Compared to the corresponding 
bulk materials, NPs are characterized by a very large specific surface 
area to volume ratio, which determines their high reactivity and 
catalytic activity. The NP sizes are suitable to interact directly with 
protein globules (2 to 10 nm), DNA helix (2 nm) and thickness of cell 
membranes (5 to 10 nm), which allows them to easily enter cells and cell 
organelles. The size of nanoparticles can be influenced by the tendency 
to form clusters in the solution[46, 47] and from the medium 
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characteristics[48]. In addition, the NP size largely determines how the 
NPs interact with the transport and defense systems of cells and the 
body, affecting their distribution and accumulation kinetics in the body. 
Larger NPs are recognized by specific defense systems of the body and 
absorbed by mononuclear phagocytes, which prevent them from 
entering other tissues, as well as it has been shown that particles 200 nm 
or larger tend to activate the lymphatic system and to be removed from 
circulation quicker[49]. Smaller particles are usually considered more 
effective drug carriers, potentiating the delivery across biological 
barriers to target tissues. NP for drug delivery may range from less than 
10 nm to around 500 nm[50, 51], while for targeted drug delivery 100–200 
nm NPs are preferred[52]. Size-dependent cellular uptake has been 
observed in different cell lines for diverse types of NP, including 
gold[53],[343], iron oxide[54], silica[55, 56], polystyrene NP[57, 58], QD[59], 
liposomes[40, 60] and polymeric NP[61, 62]. Nanoparticles can also cross the 
Blood Brain Barrier (BBB), providing sustained delivery of medication 
for diseases that were previously difficult to treat[63]. The optimum size 
for a nanoparticle to pass through the BBB is approximately 100 nm. At 
this size, immediate clearance by the lymphatic system is avoided and 
sufficient amount of drug can be delivered. Ultimately, NP size dictates 
how cell in the body ‘‘see” them and thus dictates their distribution, 
toxicity, and targeting ability. 
PDI 
With respect to particle size distribution characterization, a parameter 
used to define the size range of the NMs is called the “polydispersity 
index” (PDI). The term “polydispersity” (or “dispersity” as 
recommended by IUPAC) is used to describe the degree of non-
uniformity of a size distribution of particles(4S, 5S). Also known as the 
heterogeneity index, PDI is a number calculated from a two-parameter 
fit to the correlation data (the cumulants analysis). This index is 
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dimensionless and scaled such that values smaller than 0.05 are mainly 
seen with highly monodisperse standards. PDI values bigger than 0.7 
indicate that the sample has a very broad particle size distribution. PDI 
is basically a representation of the distribution of size populations 
within a given sample. The numerical value of PDI ranges from 0.0 (for 
a perfectly uniform sample with respect to the particle size) to 1.0 (for a 
highly polydisperse sample with multiple particle size populations). 
Values of 0.2 and below are commonly deemed acceptable in practice 
for polymer-based nanoparticle materials. 
Shape  
The shape of the particles is also an important parameter that affects 
pathways by which particles enter the cells, lifespan and cycling time, 
targeting effect, ability to overcome biological barrier, because it is more 
likely to influence the particles in the blood transport, especially in small 
vessels and tumor vessels, and how cells perceive and respond[64-68]. In 
hydrodynamics, the shape plays an important role in the transport of 
particles in the fluid and is well recognized[69, 70],[344]. In particular, shape 
and shape correlation factors, such as aspect ratio or geometric 
structure, can affect the transport properties of particles and the 
interaction between the cells and the particles[71]. Moreover, particles 
shape is important for many different aspects, influencing drug delivery 
and tumor permeation[72], toxicity[73-78], interactions with the immune 
system[79-82], redox activity[83]. 
Surface charge and properties  
The surface properties of NPs play an important role in determining the 
interactions of NPs with biological systems[84, 85] because are strictly 
involved in various biological performances of the nanoparticles[86-91] 
such as solubility, biodistribution, stability, cellular uptake, cytotoxicity.  
The experimental results of Tang and coworkers[92] showed that when 
the nanoparticles are dispersed in the culture medium, only positively 
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charged particles can be ingested by the cells. The cell membrane is 
negatively charged, sometimes with a small amount of positive charge 
of the patch; the positively charged particles are more easily adsorbed 
than negatively charged or neutral particles by cell membrane[93, 94]. 
If the particles are bound to proteins, the electrostatic difference 
between the positively and negatively charged particles can be 
eliminated.  
Positively charged NPs have an enhanced capacity for opsonization, i.e., 
adsorption of proteins facilitating phagocytosis, including antibodies 
and complement components, from blood and biological fluids[95]. The 
adsorbed proteins, referred to as the protein corona, may affect the 
surface properties of NPs, aggregation characteristics and/or 
hydrodynamic diameter of NPs. In addition, adsorption of proteins on 
the NP surface leads to their conformational changes, which may 
decrease or completely inhibit the functional activities of the adsorbed 
proteins. Binding to NPs alters the protein structure, which leads to the 
loss of their enzymatic activity, disturbance of biological processes, and 
precipitation of ordered polymeric structures, e.g., amyloid fibrils[96]. 
This may lead to various diseases, such as amyloidosis. Thus, 
modification of the NP charge allows their localization and toxicity to 
be controlled, which could be used for developing effective systems for 
delivery of chemotherapeutic drugs to tumors. 
Surface charge can be modified by functionalization, which can 
influence the interaction of cells with NPs. The surface electrostatic 
charges could be modified by grafting differently charged polymers. 
PEG (polyethylene glycol) or folic acid is often used to improve the NP 
intracellular uptake and ability to target specific cells[97],[98]. Other 
substances, such as methotrexate, polyethyleneimine, and dextran, had 
also been used to modify NP surfaces and their charge[345]. Xu and 
coworkers developed a method for changing the NP charge from 
negative to positive via various modifications of the surface[7]. 
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Hydrophobicity is another crucial parameter in determining the 
interaction with cells. When NPs constituted of materials entirely 
hydrophobic or mainly composed by hydrophobic surfaces are exposed 
to an aqueous environment, their hydrophobic portions prefer to depart 
from water molecules by aggregating unsymmetrically with each other. 
Therefore, these hydrophobic exogenous ligands mimicking a danger 
signal act as an immunostimulatory alarm, being easily detected by 
specific surface receptors that trigger inflammation and generate an 
innate immune response[99]. NP surface hydrophobicity influence the 
uptake by APC[100] and increases opsonization by serum proteins 
causing higher uptake by APC and further clearance from circulation[101, 
102].  
Incorporation of appropriate targeting ligands, surface curvature and 
reactivity are among the most used modifications in nanoengineering. 
Coating the NP surface with polymers or surfactants like polyethylene 
glycol (PEG), polyethylene oxide, polyoxamer, poloxamine, and 
polysorbate 80 to neutralize the charge and increase the hydrophilicity 
of the NPs is one of the most used strategies to stabilize the particles, 
avoiding the recognition by the immune system[103-105],[346]. The coating of 
NP surface with natural cell membranes, such as red blood cells, is 
another approach to overcome the immune recognition and increase 
pharmacologically relevant characteristics of NPs without changing 
surface functional groups[106]. Other strategies that have also been 
reported are functionalization of NP surface with polysaccharides 
moieties, such as chitosan[107, 108] or mannose[109, 110], or addition of 
antibodies specific to DC receptors, such as anti-DEC205 or anti-
CD40[111, 112]. 
Metal NPs  
Metals constitute a large portion of periodic table and have a huge range 
of chemical activities, which controls their reactivity towards living 
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cells. Among inorganic NMs, metal and metal oxides NPs have thus 
attracted the interest of both basic and applied researches. These 
particles are considered promising multifunctional platforms, due to 
their peculiar photonic, electronic, magnetic, catalytic properties and for 
the resistance to corrosion and oxidation, non-reactiveness, high 
reduction potential, high melting point, high ionization energy and 
therapeutic properties, as well as for their versatile methods of synthesis 
and surface functionalization[347]. Due to these exceptional properties, 
metal NPs have been widely applied in fast moving fields like 
environmental remediation, water purification, antimicrobials and 
industries involved in manufacturing consumer goods such as cosmetic 
products, toothpaste, soaps, shampoos, detergents[113-115], [348]. The 
physico-chemical properties of metal and metal oxide NPs can be 
dictated by various attributes like size, shape, architecture, crystallinity 
and composition[116-118]. One of the characteristics that have great impact 
on biological applications of metal NPs is particles dissolution, which is 
defined as a dynamic process in which the molecules of a material 
moves from the surface of the NPs to the solution in which it is 
suspended[380]. In the case of metal and metal oxide NPs, the release of 
metal ions from particles is of much concern and it has been studied 
deeply[380-384]. Dissolution rate is dependent on various factors, from NPs 
physico-chemical properties (crystallinity, shape, size) to the 
characteristics of the dispersant medium (pH, ionic strength, presence 
of organic molecules[381]). The dissolution of the NPs should be assessed 
for each experimental condition applied, in order to determine its 
extent.  
In the biomedical field, the most exploited metal-based NPs are silver 
(Ag), gold (Au) and iron (Fe) nanoparticles. Ag NPs are renowned for 
their biocide activity[41, 119, 120]. Au NPs, thanks to their photoactivation 
capability, inert character and biocompatibility, are efficiently used as 
therapeutic agents for cancer treatment, as medical tools for bioimaging 
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and biosensing[121, 122]. Iron NPs are already used successfully as imaging 
agents and are gaining more and more importance as drug delivery 
systems as therapeutic and theranostic compounds and in other medical 
applications[5, 36, 123-125].  
In the industrial sector, Ag NPs are used in food packaging and to 
prolong the shelf-life of various products because of their antimicrobial 
properties[16, 116, 126]. Zinc oxide NPs (ZnO NPs), because of high 
photocatalytic efficiency, are widely employed in a variety of devices 
including cosmetics, toothpaste, sunscreens, fillings in medical 
materials, textiles, wall paints, and other building materials[349]. 
Titanium dioxide NPs (TiO2 NPs), a common food additive and 
excipient used in nutraceuticals, pharmaceuticals and toothpaste[127-129]. 
However, their positive effects are constantly combined with the 
concern for the negative effects that these particles might have. Their 
interactions and effects are constantly under investigation, from 
controlling the environmental safety[130-135] to monitoring of the effects 
on human health in unintended exposure[11, 136-141]. 
Among metal NPs, nanostructures of iron, cobalt, and nickel are known 
to exhibit superparamagnetic properties and high magnetic 
susceptibility, as well as being relevant under the toxicological point of 
view. Here onward are reported some of their specific properties, 
applications and studies on possible toxic effects. 
Iron-based NPs  
Regarding elemental or zerovalent iron NPs (Fe NPs), they are widely 
used for the groundwater and soil remediation from pollutants[142], [350] 
as well as heavy metals[118, 143]. 
Iron oxide such as hematite (α-Fe2O3), maghemite (γ-Fe2O3) and 
magnetite (Fe3O4) are within the most studied magnetic nanoparticles. 
Their improved colloidal stability, biocompatibility, and magnetic 
properties persistence in comparison with other magnetic NMs make 
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them excellent candidates for biomedical applications[5, 144-146] ,[351], such 
as diagnostic imaging, cell labeling, site-directed drug delivery[124], anti-
cancer hyperthermia therapy[125], gene delivery, tissue repair, cell 
separation, photothermal therapy[36] and magnetic resonance imaging[24, 
25]. 
α-Fe2O3 (hematite) contains Fe3+ ions distributed at their octahedral 
sites. In the case of γ-Fe2O3 (maghemite), Fe3+ cations are distributed in 
octahedral and tetrahedral sites along with Fe2+ cation vacancies located 
at octahedral sites. Fe3O4 (magnetite) differ from other IONPs due to the 
presence of both Fe2+ and Fe3+ combinations, where divalent ions are 
organized at the octahedral sites and trivalent ions are split across the 
tetrahedral and octahedral sites.  
Studies on their possible toxicity are systematically being conducted in 
many fields, from immunology to environmental sciences, to address 
possible problems arising from their extensive use[123, 133, 139, 147, 148]. 
Cobalt-based NPs  
Recently, Co NPs are attractive for electromagnetic wave absorption 
applications such as development of wireless communications and high 
frequency circuit devices[352], as well as for recording media, magnetic 
sensors, magnetic memories, magnetic fluids, magnetic composites and 
catalysis[149, 150], [347], [353], [354]. Co NPs also have an intrinsic advantage in 
biomedical related fields, e.g., drug delivery and magnetic resonance 
imaging[151, 152], [355], where all these applications demand high quality and 
purity to avoid alteration in their magnetization or response stability. 
However, Co NPs aggregates are toxic on different cell lines. Toxicity is 
mainly due to Co ion dissolution from the Co NPs, and their effects in 
vivo need to be deeply investigated[153], [356]. 
Cobalt oxide (Co3O4) NPs are increasingly being used in applications 
like the production of pigments, sensors, in electrochemistry and in 
energy storage devices production[357], [358]; furthermore, 
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functionalization with biologically active molecules could open a path 
also for the exploitation of their great magnetic properties in biology[154, 
155].  
However, toxicity must always be considered, since cobalt is a heavy 
metal and can raise safety issues[25, 156, 157]. Co3O4 NPs can easily penetrate 
passing through wound, abrasions and damaged skin causing toxicity 
in human epidermis[359]. Under the occupational point of view, hard 
metal industry workers who are frequently exposed to NPs are reported 
to be more prone to lung cancer[158]. 
Nickel-based NPs 
Nickel NPs (Ni NPs) find application in modern industry as catalysts, 
sensors and in electronics[159], [360]. Nickel oxide (NiO) NPs are utilized in 
various applications such as solar cells, catalysts, lithium-ion batteries, 
resistive RAM, light-emitting diodes, electrochemical sensors and 
biosensors[12, 160, 161]. 
However, their usage is creating concerns due to the potential risk 
associated to the toxicity of Ni-derived compounds that may be released 
from Ni NPs into the environment. The International Agency for 
Research on Cancer (IARC) has classified the Ni-derived compounds as 
"carcinogenic to humans" (Group 1) with genotoxic and mutagenic 
activities[162]. Ni NPs can induce lung epithelial and respiratory 
pathologies in human[163, 164], embryotoxicity in zebrafish and 
spermiotoxicity in Ciona intestinalis[74, 165]; NiO NPs were assessed to 
cause oxidative stress in different cellular models, and in vivo 
experiments when inhaled[166-168]. 
Protein Corona  
To achieve a detailed understanding of NP interactions with cells, 
tissues, and organisms it must be taken into account that in the complex 
biological environment of living organisms, proteins and other 
~ 23 ~ 
 
biomolecules in biological fluids (e.g., blood and lung-lining fluid) 
spontaneously form an adsorption layer on the NP surface, the so-called 
opsonization or biomolecular corona[169-174], [361] (Figure 2).  The protein 
corona properties need to be known in detail because the adsorption 
layer is as much important as the NP surface in the interactions with the 
living organism and governs physiological responses, including cellular 
internalization, biodistribution, and toxicity[174-177]. Due to the high 
surface to volume ratios of nanomaterials, on the nanoscale the protein 
corona formation impact on NPs or the NP−biomolecule conjugates can 
heavy influence the characteristics of the nanomaterials. Many 
investigations have shown in detail how biomolecular adsorption can 
be influenced by NP properties[39, 44, 169, 172], [361]. 
 
Figure 2: Biological Corona at different scales (modified from[173]) 
Common biological fluids are typically aqueous solutions with ions and 
biomolecule in high concentrations (typically hundreds of mM), which 
could interact with the surfaces of nanomaterials. Blood and serum are 
incredibly complex, with over thousands of different species of proteins 
at concentration greater than 80 mg/mL, which is a completely 
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different environment from the organic solvents or gaseous phases in 
which nanomaterials are often produced. 
Biofluids contain a vast number of different biomolecules, especially 
proteins, which may be considered as a “cloud” around the NP. Some 
will adsorb reversibly to the NP surface and form a monolayer. 
Adsorption may be accompanied by (partial) unfolding, which could 
expose hydrophobic moieties, that may adsorb further proteins as a 
second layer; polypeptide chains of globular proteins expose 
hydrophobic moieties and thus interact with the NP surface and other 
proteins in the biofluid in distinctly different ways than native proteins. 
NPs covered with unfolded proteins may undergo protein-mediated 
aggregation.  
Nanotoxicology 
Nanotoxicology - defined as “science of engineered nanodevices and 
nanostructures that deals with their effects in living organisms”[38] - is 
nowadays established as a key discipline in the “nano” world. 
Nanotoxicology research not only provides data for safety evaluation of 
engineered nanostructures and devices but also helps in advancing the 
field of nanomedicine, by providing information about their 
undesirable properties and means to avoid them, as well as dictating 
some regulatory passages in the approval of newly synthetized 
nanomaterials. 
Toxicity  
At a systemic level, many studies aim at assessing the toxicological 
outcomes of human exposure to NPs[1, 11, 136-141]. Many experiments are 
also being conducted, modelling the toxic effects of NPs on the body[178-
181].  
The increase in production, use, disposal of NPs and their waste 
treatment produces an environmental release of nanoparticulates, in 
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their original or modified forms[130-135]. The effect of this release needs to 
be considered and investigated. 
However, it is the effects that NPs exert at the cellular level that 
mediates their toxic effects in organisms[1, 4]. A summary of the most 
common mechanisms of NP cytotoxicity are schematized in Figure 3:  
 
Figure 3: Main toxic effects of NPs on cells[4] 
1. Cell membrane damage[182, 183], [362], [363] 
2. Cytoskeleton damage[184-186] 
3. Transcription disturbance and DNA damage[187-190], [364], [365] 
4. Mitochondria damage and energetic metabolism imbalance[191-195]   
5. Alterations of intracellular vescicles trafficking[196-198] 
6. Oxidative stress induction[199-202], [364]   
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7. Interactions with membrane proteins, leading to membrane transport 
impairment or abnormal functionality[203-205]   
8. Inflammatory mediators production[206-209] 
Like for the NPs mechanism and activity inside the body and the 
interactions with cells, NP physical and chemical characteristics play a 
major role in causing their toxic effects[1, 3, 4, 39, 42]. According to 
toxicological data, the toxicity of NPs depends on various factors:  
 Dose and exposure time. Dose is defined as the amount of a 
given substance that reaches the biological system; it is directly 
related to exposure, which is the concentration of substance in 
the medium (air, food or water) multiplied by the duration of 
contact. For NPs, rather than mass dose[38, 210, 211], toxic effects 
correlate better with nanoparticle surface area rather than mass 
dose [38, 212, 213]. 
 Size, aggregation and concentration. NPs show a size-
dependent toxicity[1, 3, 4, 42]. Toxicological studies have 
demonstrated that small nanoparticles (<100 nm) cause adverse 
respiratory health effects, typically causing more inflammation 
than larger particles made from the same material[38, 211, 212, 214-216]. 
When particles smaller than 100 nm are compared, still-smaller 
particles are more toxic than larger ones[217, 218]. Aggregation state 
is strictly related to NP size, due to a more effective macrophage 
clearance for larger particles compared to smaller ones (that 
seem to easily evade this defence mechanism), leading to 
reduced toxicity of NP aggregates larger than 100–200 nm[38, 219]. 
Most aggregates are larger than 100 nm, a size that seems to be 
a threshold for many of the adverse health effects of small 
particles. A high concentration of nanoparticles would in the 
end can promote particle aggregation, and therefore reduce 
toxic effects compared to lower concentrations[214, 219, 220].  
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 Surface area. Typically, the toxicological effect of NPs increases 
with decreasing particle size and increasing surface area[1, 3, 42]. 
For the same mass of particles with the same chemical 
composition and crystalline structure, smaller nanoparticles 
have a larger specific surface area and particle number per unit 
mass, and thus more available surface area to interact with 
cellular components[221]. In some nanoparticles, toxicity was 
found to be a function of both size and surface area[200]. The 
higher surface area of nanoparticles causes a dose dependent 
increase in oxidation[211] and DNA damage[222] much higher than 
larger particles considering the same mass dose[38, 211, 216]. 
 Particle shape. NPs exhibit shape-dependent toxicity, that is, 
different toxicity levels at different aspect ratios (length/width)[3, 
4, 39, 42, 73-78]. For example, it was found that lung cancer was 
associated with the presence of asbestos fibres (which are very 
studied for their interactions and toxicity on the biological 
matter) longer than 10 µm, mesothelioma with fibres longer than 
5 µm, and asbestosis with fibres longer than 2 µm[223]. Long-
aspect-ratio engineered nanoparticles, such as carbon 
nanotubes, have attracted a lot of attention due to their possible 
negative health effects[224-233]. Nanotubes are in general 
considered very toxic, inducing cell death at sufficiently high 
doses[233, 234], while low doses seem to be tolerated[231]. However, 
the multitude of morphological variants, sizes, and chemical 
functionalization of the surface or ends adds further complexity 
to the toxic effects comprehension. It is generally accepted that 
fibre-shaped NPs of a given material are more biologically active 
and toxic compared to spherical particles[235], [366]. 
 Surface characteristics. Particle surface plays a critical role in 
toxicity as it contacts cells and biological material and may affect 
the cellular uptake of particles as well as how the particles 
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interact with organelles and biomolecules[3, 4, 39, 236], [367]. Charged 
NPs tends to be more cytotoxic than their neutral forms[84], and 
positively charged ones act more cytotoxically than negative 
variants of similar sizes in nonphagocytic cells[56, 237-239], [368].  
Hydrophobicity is another key-parameter and is often linked to 
surface charge, since NPs with hydrophobic surfaces are more 
cytotoxic than the respective noncoated NPs[240, 241]. Surface 
coatings can render noxious nontoxic NPs, while less harmful 
particles can be made highly toxic with the addition of active 
molecules on their surfaces[211, 222], [367] that leads to the creation of 
reactive oxygen species and the induction of inflammation. 
 Crystal structure. Based on the crystal structure, NPs may 
exhibit different cellular uptake, oxidative mechanisms and 
subcellular localization[214, 242]. 
Particle Entrance Routes  
The internal compartments of the body can come into contact with NPs 
through four main ways (Figure 4): the respiratory system[243-246], [369], the 
olfactory epithelium and nerves(Oberdorster 2003, messicani,), the 
gastrointestinal tract[247-251] and the cutaneous route[252], [370]. 
Nanostructures, once inhaled, ingested, or administered topically, can 
reach the bloodstream and be transported and accumulated at the level 
of various organs, exerting their effects on cells that are located there.  
The interactions of NPs with biological systems, including their 
entrance into cells, play a key role in executing their functions and 
eventual toxicity. In fact, it is known that the NPs small size can easy 
penetrate into the cells and translocate among different cells, tissues and 
organs that are remote from the portal of entry to the body, ultimately 
representing a great risk to human health. 
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Figure 4: main NP entrance routes in the body 
Systemic and tissue entrance routes 
Airways are one of the main routes by which the human body comes 
into contact, voluntarily or accidentally, with NMs. The respiratory 
system consists of two parts: the upper respiratory tract, which includes 
the nasal cavity, the pharynx, and the larynx, and the lower respiratory 
tract, which includes the trachea, the bronchi and the lungs. Each 
bronchus is branched in small structures called bronchioles that 
terminate with the alveoli, where the gas exchange takes place. The 
particles, in general, are deposited in the whole respiratory tract, from 
the nasal cavity to the alveoli, through diffusional mechanisms[253].  
Two possible internalization pathways, leading to different outcomes 
for the organism can take place in the airways: the absorption of the 
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particulate from the nasal mucosa that gives direct access to the brain 
and the deposition and accumulation in the lungs. 
The nasal cavity can be divided into the respiratory region, from which 
the trigeminal nerve departs, and the olfactory region, from which the 
olfactory nerve departs[385, 386]. Along both these nerves, the movement 
of molecules and materials from the nasal cavity to the parenchyma of 
the brain occurs. The internalized materials are delivered to the origins 
of the nerves in the pons and cerebrum, respectively, dispersing freely 
throughout the brain. This process occurs via intracellular and 
extracellular pathways. The intracellular pathway starts with 
internalization of the material by an olfactory neuron, trafficking of the 
endocytic vesicle within the cell to the neuron's projection site, and 
finally release via exocytosis. The extracellular pathway begins with the 
material crossing the nasal epithelium to the lamina propria, before 
being transported externally along the length of the axon by bulk flow 
processes to the Central Nervous System. This internalization route has 
been studied extensively over the years, for its toxicological 
implications[137, 387-390] and recently for the possible exploitation for drug 
delivery bypassing the BBB[385, 386, 391, 392]. 
Concerning accumulation in the lungs[254, 255], the size distribution of NPs 
plays a major role in their ability to enter the human respiratory system. 
Larger particles, with a diameter between 5 and 30 µm, usually remain 
in the nasopharyngeal region, whereas smaller particles, with a size 
between 1 and 5 µm, tend to deposit in the tracheobronchial region. 
These inhaled materials are usually trapped in the respiratory mucus 
that lines the respiratory epithelium from the nose to the terminal 
bronchioles. NPs (0.1–1 µm) can reach the alveolar region, which is the 
deepest region of the respiratory system, by gravitational sedimentation 
and Brownian diffusion[371, 372]–(6S). Overall, the size distribution of the 
particles markedly influences the possible target areas of the 
nanoparticles in the airways. Key-issues in particle deposition in the 
~ 31 ~ 
 
lungs include the dynamic behaviour of particles in an aerosol, 
influencing the aerodynamic particle size through agglomeration or 
aggregation of primary particles. At the end, the particle size is crucial 
in determining how deep in the respiratory tract the particles can 
enter[255], [373]. The small NPs can thus settle and be absorbed, since the 
elimination mechanisms are not fast; many toxics effects can be 
generated because of the prolonged interaction with cells[374], as well as 
can be adsorbed by the pulmonary epithelium and reach the pulmonary 
interstitium, where they can subsequently be phagocytized by alveolar 
macrophages or enter the bloodstream directly or via the lymphatic 
pathway[136, 210, 255, 256], [373]. In conclusion, NP size is the main 
physicochemical property for the effects on the airways; smaller NPs are 
able to spread and accumulate in the deepest regions and trigger 
inflammations and ROS production[257-261]. 
Nanoparticles can also enter the human body via the gastrointestinal 
apparatus. It has a large surface area (200 m2) and comprehends the 
mouth, the esophagus, the stomach, and the small and the large 
intestine and the anus, each with specific functions. This apparatus 
represents a mucosal barrier that selectively promotes the digestion and 
the absoption of nutrients. Humans can ingest directly a lot of food 
additives and supplements containing NPs[247, 262]. The gut route is thus 
potentially important for the absorption of NMs contained in consumer 
products[263], as well as for secondary ingestion of inhaled particles[264]. 
In general, the Gl tract undergoes the exposure of ‘exogenous’ and 
‘endogenous’ NPs[265, 266]. 
Once in the gut, NPs may exert effects locally[262, 267]. For instance, the gut 
microbiota (the community of organisms living within the 
gastrointestinal tract) may have a relevant role in modulating both local 
and systemic biological effects of NPs[268]. NPs can also translocate into 
the bloodstream after crossing the GI mucosa by different routes and 
consequently access any organ[269].  
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Different chemical and physical conditions can be found along the GI, 
such as variations of the pH value[126] and of the pressure[270], that can 
influence heavily the NP characteristics and absorption.  
The stomach is characterized by an acidic environment with an early-
stage pH range of 1.2–2.0. When the bolus is formed, however, the pH 
reaches values of c.a. 5.0, followed by slow re-acidification[271]. The 
dissolution of NPs at a low pH promotes their further degradation in 
the digestive fluids. 
Digestion and absorption processes are carried out by the small 
intestine that, at the duodenum, has a pH value between six and 
seven[247]. The enhancement of the absorptive surface is due to the 
presence of villi and enterocytes, and it is the absorption site of NPs. The 
major cell types in the small intestine are absorptive enterocytes, mucus 
secretory goblet cells and the immune sampling microfold cells (M-
cells)[247, 272]. The M cells are associated with lymphocytes, immunoblasts, 
plasma cells and macrophages. Large NPs and microparticles can cross 
the intestinal epithelium through transcytosis by M-cell-uptake and 
persorption by M cells and the intestinal enterocytes. NPs can trigger 
oxidative stress, DNA damage and inflammations[273]. Moreover, NPs 
can cross the villi through the gaps formed in the apical zone due to a 
dysfunction process induced by NPs altering the morphology of the 
epithelium[274]. NPs paracellular uptake is a rare process but, in some 
disease, the tight junctions of cells can be altered, promoting the passage 
of NPs[247].  
Another organ exposed to NPs is the skin, which is the largest organ of 
the body with a surface area of about 1.2–1.3 m2 and a thickness less 
than 2 mm. It consists of three layers: the epidermis, dermis and 
hypodermis[275], [372]. The skin is a dynamic organ that has different 
functions, such as protection against external agents, UV protection and 
a selective permeable barrier. The topmost sub-layer of epidermis, 
stratum corneum poses a rate limiting barrier for diffusion[276-278]. The 
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dermis layer is composed of elastin and collagen fibers that provide 
mechanical support of skin. It is highly vascularized and permeable to 
solutes. 
Nanomaterials contact with skin can lead to adverse consequences. 
Certain metals, such as nickel, are also known to cause dermatitis. 
Estimates of possible dermal exposure to manufactured NMs in the 
workplaces[158, 279], [359] have been reported. Furthermore, since 2006, NP-
containing cosmetics have shown a large diffusion[280]. It has been 
estimated that cosmetic products contain TiO2 NPs (70/80%), ZnO NPs 
(70%) and Ag NPs (20%)[375], [376]. However, the three layers of skin make 
it difficult for ionic molecules to penetrate through. Now, no clear 
evidence exists on the penetration of NM through intact or even 
damaged or inflamed skin into the systemic circulation[281]. It is probable 
that dermal exposure may lead to penetration of nanoparticles into the 
superficial layers of the skin, the dermis, causing there a local 
inflammatory reaction[158, 282], [359]. 
Cellular entrance routes 
The design of new biological functions or the prediction of the 
toxicological consequences of NPs require the knowledge of their 
interplay, intended or incidental, with target cells. At the cellular level 
(Figure 5), NPs can enter into cells through endocytosis (which is the 
most widely described mechanism) and through direct penetration 
(which as enormous potential in terms of potential applications, as well 
as that should be monitored in terms of toxicological activity of the 
particles, but that has been documented for a limited number of cases). 
Physicochemical characteristics of NPs influence their internalization 
mechanism and biological barriers crossing[1, 283-285], [377]. Cell types also 
play a significant role, since each cell type might have different uptake 
mechanisms and can react differently to NPs[286, 287].  
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Figure 5: possible NP entrance routes in the cells[288] 
Endocytosis route for NPs can be divided, according to the cellular 
machinery involved in the internalization processes, in phagocytosis, 
macropinocytosis, clathrin-mediated, caveolin-mediated, and non-
clathrin and non-caveolin-mediated endocytosis[183, 288, 289]. All endocytic 
pathways lead to the internalization of the NPs in an intracellular 
vesicle. Depending on their physical properties and on the cell type, 
NPs can utilise all four of the endocytosis mechanisms to enter the cell. 
Phagocytosis is triggered in professional phagocytes (i.e., 
monocytes/macrophages, neutrophils, and dendritic cells) by the 
detection of opsonins adsorbed on the surface of the NPs, which leads 
to the polymerization of actin filaments at the site of ingestion and to 
the internalization within a vesicle, which is then transported to the 
lysosome for digestion, thereby forming the mature phagolysosome[210, 
219, 242]. 
Pinocytosis (or macropinocytosis, for larger vesicle formation), is a non-
specific route where the membrane invaginates (actin mediated 
process) and engulfs large volumes of extracellular milieu and then 
collapse and fuse with the plasma membrane to generate large 
endocytic vesicles called macropinosomes; is primarily used for the 
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uptake of fluids and other essential generic materials required for the 
cell such as salts, glucose, and amino acids[290-292]. 
Clathrin-mediated endocytosis is a form of receptor mediated 
endocytosis, which is in general very fast, occurs in all mammalian cells 
and carries out the continuous uptake of essential nutrients. The peptide 
clathrin, binds to the protein known as adaptor protein 2 which is bound 
to the receptor protein embedded in the inner membrane of the cell. The 
membrane bound clathrin molecules link with each other, forming a 
spherical cage and leading to the formation of a vesicle, which is 
subsequently released with the aid of dynamin (a GTPase that wraps 
itself around the vesicle neck and constricts, collapsing the neck and 
freeing the vesicle from the membrane) following the ligand binding[290, 
293-299]. 
In caveolin dependent endocytosis, the protein caveolin integrates itself 
within the cholesterol rafts present in the membrane. This leads to the 
formation of caveolae, which are static, flask-shaped invaginations of 
the plasma membrane, whose release is dynamin-mediated. It is usually 
involved in the transport of serum proteins and its uptake rate is 
relatively slow[300-303]. 
However, increasing evidences are nowadays present, sustaining the 
hypothesis that NPs do not necessarily undertake the endocytosis 
process to enter a cell; this mechanism shall be treated in deeper details 
in the following subsection. 
Direct Membrane Penetration  
Understanding in more details the interactions occurring between NPs 
and the cellular membrane that lead to membrane direct crossing would 
be of extreme importance in establishing a new path to get access to the 
cell cytoplasm, opening new possibilities in the nanomedicine world. 
The endocytosed nanoparticles are confined in the endosome, and their 
“escape” is very complicated even with strategies developed ad hoc and 
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with low success rate; their overall functionality is thus limited to the 
endosome, with very low therapeutic efficacy. By directly penetrating 
the membrane, there will be no lipids coated on their surfaces and NPs 
will be free to exert their effect where they will be designed to. However, 
there is very limited information available on direct membrane crossing 
and on which NP characteristics dictate this mechanism, as well as on 
which characteristic of the cell or of the cell microenvironment could 
play a role in this. Studies reported that the intracellular localization of 
some nanomaterials may be related to alternative pathways for particles 
to enter cells[304-307]. 
First, it must be considered that the plasma membrane is a highly 
complex system, acting as a cellular barrier with selective permeability 
to maintain a homeostatic environment within the cell. The cell 
membrane consists of a self-assembled bilayer of a mixture of different 
lipids and proteins, it is responsive to external stimuli such as chemical 
and mechanical forces, electrical and thermal stresses, and it is 
responsible for communicating with other cell membranes and 
transducing signals inside. The proteins embedded in the membrane 
have different roles, these proteins included channels, receptors, 
transporters, and cellular adhesion molecules. To add further 
complexity, approaching the cell membrane the NPs will encounter a 
layer of negatively charged oligosaccharides (glycolipids and 
glycoproteins), which has several functions and also acts as receptor for 
macromolecule internalisation[308] or as a macromolecular repellent, 
further complicating the internalisation behaviour of NPs[309]. Cell 
membrane integral proteoglycans have been demonstrated to have a 
key role in binding of nanoparticle-sized lipoproteins[310], as well as 
lipopolysaccharide membrane components dramatically affect binding 
of amphiphilic macromolecules[311, 312], [378]. Charge inhomogeneity on the 
cell membrane surface adds even further complexity, with positively 
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charged NPs are believed to be attached to negatively charged areas[217, 
313]. 
It is clear that NPs interact with a biological barrier of great complexity; 
hence, different mechanisms have been proposed to explain this 
phenomenon according to the difference that can be found in the 
membrane characteristics. The mechanisms described or hypothesized 
range from passive diffusion through membrane pores or specialized 
membrane transport protein channels[308, 314], to the occurring of van der 
Waals forces, electrostatic charges, steric interactions, physical 
interactions or interfacial tension effects leading to passive 
permeation[141, 304, 305], [379], to direct permeation through the cell 
membrane inserting into the hydrophobic membrane interiors and then 
leaving from the membrane[310, 311] and to the creation of nanometer-size 
pores on the membrane to translocate[312, 315], [378]. Different experimental 
approaches have been performed, to discriminate and identify among 
the particles properties some “guidelines”, some indications of which 
are the most influent characteristics that dictate the membrane direct 
permeation. 
Molecular dynamics computer simulation studies have been used to 
recreate through computational models the bio-nano interface and 
mimicking the hypothesized interactions[288]. This approach is very 
powerful and led to the identification of some conditions in which 
effective membrane penetration could be potentially achieved. These 
can be due to NPs charge[316-319], NPs surface properties[320]. Molecular 
dynamics study suggests different experimental conditions to monitor 
the NPs possible effects[316, 321-323]. Simulations are thus very useful, but 
their results need to be verified through practical experiments. 
The use of artificial membranes and liposomes could address some of 
the issues related to membrane complexity. These tools may provide a 
membrane platform of controlled composition and with tuneable 
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properties, resulting suitable to focus mainly on the NPs-related 
characteristics.  
Interesting results have been achieved using liposomes, supported lipid 
membranes or bilayer models and experimental techniques involving 
fluorescent probes, microscopy. Electrophysiology and the 
determination of physical characteristics of the membrane has been also 
applied. 
 Passive permeation was observed and related to particle charge, 
surface characteristics and chemical composition[324-328][379][329], or to 
particle size[305, 330], or to the combined effects of these parameters[315, 331, 
332]. These studies are considered valuable to optimize engineered 
particles composition and surface characteristics but remain a 
simplification of a more complex situation (for example, considering 
protein role in the interactions in these models is impossible). The use 
of cells remains thus inevitable, to verify the simulations and in the vitro 
data and to test the real interactions occurring among membrane and 
NPs.  
A wide range of approaches has been applied to determine the effects 
of membrane direct crossing in physiological conditions in cells. The 
experimental studies conducted focused on different aspects of cell-NP 
interactions, from the role of physicochemical parameters alone or in 
combination, such as charge, size and aggregation state[182, 305, 328, 333-336], 
and studying other possible mechanisms or issues[304, 337, 338]. Through 
fluorescent probes, the physiological parameters of the cells were 
monitored, to assess changes in cellular potential and membrane 
integrity, and by microscopy was verified the intracellular presence of 
the particles[334, 335] [304, 336]. A study from Chen and coworkers reported 
the direct effects of NP interactions on cell membranes by 
electrophysiology[333], highlighting that the access to the cytoplasm is 
paralleled by the formation of nanoscale defect, which could account for 
a pore. 
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However, it is not fully understood which chemical and physical 
properties of the cellular membrane and particles (or what combination 
of these properties) are responsible for the translocation of 
nanomaterials into the cells, the nucleus and organelles, either in vitro 
or in vivo, and the comprehension of this entrance route is far from 
being achieved. The complexity of the processes involved in 
nanomaterial uptake by cells and the complexity of the cell membranes 
make these interactions more difficult to study and to understand in real 
time.  
In this scenario, we focused on a special kind of cell: the Xenopus laevis 
oocytes, to develop a platform for the screening of the effect of NPs on 
the membranes. These cells are suitable for study passive permeation 
mechanism for their resting state, where the endocytotic mechanism are 
extremely reduced in standard condition. Moreover, these cells are easy 
to maintain in saline solution giving, the possibility to test NPs in the 
absence of protein in the experimental medium (avoiding protein 
corona). 
These cells could provide a useful tool, which can be used to work with 
fluorescent probes to monitor intracellular environment for the 
presence of a specific ions or for a change in cytoplasm condition such 
as pH or voltage. Electrophysiological techniques, and in particular two 
electrodes voltage clamp, in Xenopus oocytes allow to follow quite easily 
membrane modification such as endocytosis phenomena or the opening 
of specific and unspecific conductances. Furthermore, the use of these 
cells as heterologous expression system allows to study selected active 
transport phenomena by overexpressing the target membrane proteins, 
it is possible to achieve high signals from these cells and to easily detect 
the protein response to the various stimuli applied. 
The passive diffusion mechanism, although occurring rarely, is by far 
the most interesting of the described mechanisms and increasing the 
knowledge about the particles properties and the cellular environment 
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implicated in this phenomenon would be of extreme importance for 
newly designed particles and therapies.  
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Outline of the project 
This Ph.D. thesis is in the form of collection of papers. Each paper 
constitutes a single chapter, from 2 to 4. Chapter 5 is a complete set of 
experiments just concluded. This is the scientific production of the 
research work conducted during my three years as a Ph.D. student in 
the Laboratory of Cellular and Molecular Physiology (LFCM) at the 
Department of Biotechnology and Life Sciences of the University of 
Insubria, under the supervision of my tutor Prof. Elena Bossi. The 
research was conducted in collaboration with the Laboratory of Cellular 
Biology of Prof. Giovanni Bernardini and Prof. Rosalba Gornati. 
Prof. Elena Bossi is an electrophysiologist with experience in the use of 
the Xenopus laevis oocytes as heterologous expression system. During 
the last 5 years the membrane transporters form Dictyostelium 
discoideum, NRAMP1 and 2, and the rat transporter (rDMT1) have been 
studied in the LFCM since they are involved in the iron transport and 
have become the starting point of my thesis. In the beginning of my 
work I have investigated the permeation of iron ions with the use of 
Xenopus laevis oocytes heterologously expressing rDMT1 and injected 
with calcein. Calcein is a fluorescent probe whose fluorescent signal is 
quenched by divalent metal ions.  
After establishing the efficacy of the method for the detection of free 
intracellular divalent metal ions, I have tested calcein-injected oocytes 
in the presence of metal NPs provided from Prof. Bernardini research 
group. This was made to understand the metal NP related toxicity, 
which is usually associated with the presence of the realized ions inside 
the cytosol[154, 339]. The oocytes were not injected with any metal 
transporters and were exposed to NPs to verify the effect in the absence 
of permeation pathways for metal ions.  
Testing oocytes with cobalt-based NPs (Co and Co3O4 NPs) showed a 
significant difference in the intracellular calcein fluorescence after 
exposure, since it was quenched by Co3O4 NPs but not by Co NPs. The 
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quenching was significantly different from that registered in control 
oocytes and was abolished when Co3O4 NPs were coated with BSA, 
pointing out a role of the NPs surface characteristics in causing the 
internalization. Endocytosis inhibitors did not alter the effect of the NPs 
exposure, suggesting that the entrance of metal and the consequent 
quenching could be due to a passive permeation mechanism followed 
by small intracellular dissolution of the NPs. 
The aims of my work were to investigate and understand the 
mechanism of the metals entrance in the cell and to verify the passive 
permeation hypothesis.  
These first findings were originally published in 2016 in the journal 
Scientific Reports as: 
Cobalt oxide nanoparticles can enter inside the cells by crossing plasma 
membranes 
Elena Bossi, Daniele Zanella, Rosalba Gornati and Giovanni Bernardini 
Scientific Reports | 6:22254 | DOI: 10.1038/srep22254 
The article is quoted in full in Chapter 2 of this thesis. 
After this, I started to test different NPs with the fluorescence probe, to 
identify NPs behaving similarly or differently from Co or Co3O4 NPs 
and to link the effects with their physico-chemical properties.  
I investigated if the NP passage through the membrane could be 
associated with modifications of membrane biophysical parameters; 
this method was suggested by a paper of Dr. Annalisa Bernareggi and 
Prof. Zabucchi from the University of Trieste, whose experimental 
activities on Asbestos fibers gave us some precious tips[340]. 
We began with iron-based NPs, namely Fe3O4 and Fe NPs, that are 
already used in medical and industrial applications. The fluorescence 
probe method allowed to verify that Fe3O4 NPs induced intracellular 
calcein quenching as a consequence of iron increase in the cytoplasm, 
while Fe NPs and Fe3O4@BSA NPs did not.  Applying specifically 
~ 43 ~ 
 
designed two electrode voltage clamp protocols, it was determined that 
the quenching is associated with modification of biophysical 
parameters like resistance, resting potential transmembrane current. 
Neither Fe NPs nor Fe3O4@BSA NPs altered these parameters. 
Furthermore, these modifications occurred only in oocytes tested within 
5 min from the addition of NPs and disappeared after 20 min. The 
characterization of the NPs properties and behaviour in experimental 
medium was conducted in collaboration with the Biomineral Research 
group of Prof. Jonathan J. Powell of the University of Cambridge. 
Particles were determined to be neutral, but a difference in sizes 
emerged, with a submicron population of Fe3O4 NPs delineating 
precisely and stable for 5 min, underlining that these smaller Fe3O4 
particles could be responsible for the effect described.  
Moreover, experiment conducted with aggregated particles (30 min 
standing time before application) demonstrated that when all Fe3O4 NPs 
were aggregated there were no modification in membrane permeability 
and in calcein intracellular fluorescence. BSA role in the modification 
NPs properties was also confirmed. 
The combination of fluorescence approach, electrophysiology and 
physico-chemical characterizations gave a more precise picture, leading 
to the publication of one work in 2017 on the journal Scientific Reports 
as: 
Iron oxide nanoparticles can cross plasma membranes 
Daniele Zanella, Elena Bossi, Rosalba Gornati, Carlos Bastos, Nuno 
Faria and Giovanni Bernardini 
Scientific Reports | 7: 11413 | DOI:10.1038/s41598-017-11535-z 
The paper is quoted in Chapter 3 in full. 
To check if what we have reported for Fe3O4 was true also for Co3O4 and 
to complete the panel of transition metal-based NPs, the two electrode 
voltage clap techniques was applied to nickel and cobalt-based NPs. 
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Co3O4 NPs resulted able to modify cell membrane biophysical 
parameters similarly to Fe3O4 NPs, while Co were not and the coating 
of BSA stabilized the particles against each other as well as towards the 
membrane, thereby preventing the membrane modifications. 
Ni-based NPs on the other hand resulted ineffective both in 
fluorescence approach and in electrophysiology. However, in the case 
of NiO particles, a submicron population was present for the whole 
experiment length; this presence allowed us to narrow the size range we 
hypothesized to be implied in the membrane modifications, since from 
the comparison between Co3O4 (effective) and NiO (ineffective) we were 
able to notice that Co3O4 possess an unstable submicron population 
below 200 nm, while NiO never go below this threshold. Aggregation 
experiments again confirmed the importance of the population <200 nm 
Co3O4 in causing the described modifications in membrane biophysical 
parameters and calcein intracellular fluorescence. 
These data have been collected in a new manuscript and submitted to 
the journal Nanotoxicology. 
The direct permeation of nanoparticles through the plasma membrane 
transiently modifies its properties 
Daniele Zanella, Elena Bossi, Rosalba Gornati, Nuno Faria, Jonathan J. 
Powell and Giovanni Bernardini 
The article submitted form is quoted in Chapter 4 
Chapter 5 is the synthesis of the work conducted on Fe2O3 NPs and on 
their surface coated form, modified covalently with the binding of 
APTES, an organosilane that could give to the particles a net positive 
charge. These particles are interesting for their magnetic properties, and 
understanding if they could undergo passive permeation entrance into 
cells would be of great interest.  
Particles were synthesized by Dr. Ilaria Armenia of Prof. Bernardini 
group. 
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The data collected show that neither Fe2O3 NPs nor Fe2O3-APTES NPs 
were able to modify membrane and reduce intracellular calcein 
fluorescence. Their physico-chemical characterization demonstrated 
that Fe2O3 NPs were neutral and aggregated promptly after the addition 
in the experimental medium. Fe2O3-APTES NPs on the other hand had 
free amino groups on their surface, hence a positive charge was 
expected, but they resulted neutral; the coating operated a partial 
stabilization, with the presence of a population around 100 nm that 
however did not interact with cell membranes.  
Chapter 6 provides a more integrated framework of the work 
conducted, highlighting for each particle type the finding related to 
membrane effect and the link to the physico-chemical properties, and 
some concluding remarks dealing with the passive permeation 
mechanism we have proposed. 
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Abstract 
The ability of nanoparticles (NPs) to be promptly uptaken by the cells 
makes them both dangerous and useful to human health. It was recently 
postulated that some NPs might cross the plasma membrane also by a 
non-endocytotic pathway gaining access to the cytoplasm. To this aim, 
after having filled mature Xenopus oocytes with Calcein, whose 
fluorescence is strongly quenched by divalent metal ions, we have 
exposed them to different cobalt NPs quantifying quenching as 
evidence of the increase of the concentration of Co2+ released by the NPs 
that entered into the cytoplasm. We demonstrated that cobalt oxide 
NPs, but not cobalt nor cobalt oxide NPs that were surrounded by a 
protein corona, can indeed cross plasma membranes. 
Introduction 
It is well known that nanoparticles (NPs) readily enter cells 1 by different 
endocytotic mechanisms 2-6. The capability of NPs to be promptly 
uptaken by the cells, as well as that of crossing biological barriers 7-9, 
makes them at the same time potentially dangerous and useful to 
human health. Dangerous, as NPs might exert their toxicity, once inside 
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the cell, very close to target organelles as nuclei and mitochondria, a 
phenomenon which is referred to as Trojan horse effect 10-12. Useful, as 
they can be directed to exert their toxicity toward cancer cells, used for 
drug delivery, injected as a contrast agent for diagnostic and even for 
theranostic purposes 13, and assumed for food supplementation. 
Recently, it has been considered the possibility that some NPs might 
also cross the plasma membrane by a non-endocytotic pathway 14-19 
gaining a direct access to the cytoplasm. This pathway is usually poorly 
considered as it challenges the idea of non-permeability of membranes 
to large hydrophilic molecules. To verify this possibility, we have set up 
a new protocol that has proved capable to follow the NP-plasma 
membrane dynamics and we have demonstrated that cobalt oxide NPs, 
but not cobalt nor cobalt oxide NPs that were surrounded by a protein 
corona, can cross plasma membranes. 
Cobalt NPs have a large use in industrial and biomedical applications. 
They efficiently catalyse the combustion of various hydrocarbons20 and 
the degradation of water pollutants21 providing a cheap candidate to 
replace noble metals. Cobalt NPs are also used in electrocatalysis for the 
oxygen evolution reaction22, important in hydrogen generation. 
Recently, it has been shown that cobalt NPs can self-assemble to 
constitute photonic hyper-crystals23, which might have a strong 
potential in biological and chemical sensing. Moreover, cobalt NPs are 
magnetic and this property allows to manipulate them in a chemical or 
biological system using an external magnet. Moreover, magnetic NPs 
can be easily conjugated to biologically important constituents such as 
DNA, peptides, antibodies24 as well as enzymes25,26 and sugars27,28 to 
construct versatile bio-nano hybrids. 
Results and Discussion 
Calcein as “Metal Detector” in Xenopus laevis oocytes. 
As a preliminary step, we have tested the ability of Calcein to detect 
cobalt uptake in fully grown Xenopus laevis oocytes. Oocytes are 
naturally arrested for prolonged period of time at prophase of meiosis I 
during which time the oocyte grows and stores macromolecular 
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components that are necessary for future development. They exhibit 
different sizes that reflect different stages of growth. Fully grown 
oocytes, which have been used in the present paper, have a diameter of 
about 1.2 mm and provide a simple system for membrane transport 
characterization. For this purpose, we firstly needed to set up a system 
capable to consistently transport divalent metal ions across the plasma 
membrane from the extracellular milieu to the cytoplasm. We have, 
therefore, prepared transfected Xenopus oocytes by injecting them with 
the cRNA of the Divalent Metal ion Transporter 1 from rat (rDMT1). 
This membrane protein is a proton and voltage dependent transporter 
of divalent metal ions such as Fe2+and Mn2+, as well as Co2+, Ni2+ and Cd2+ 
29-32. In mammals, it is mostly expressed in duodenum enterocytes, but 
it can be also found in kidney, brain, testis and placenta. By a two 
electrode voltage-clamp with a holding potential of -40 mV, we have 
recorded the currents generated by the exposure to manganese, iron and 
cobalt ions at pH 5.5. In non transfected (i.e., not injected with DMT1 
cRNA) Xenopus laevis oocytes, the perfusion of ions in the bath solution 
did not elicit currents indicating the absence of electrogenic endogenous 
transporters in their plasma membrane. Conversely, in rDMT1 
transfected oocytes, all the three substrates elicited, as expected 33, 
inward currents in the range of -40 to -50 nA (Figure 1 A and B). As 
shown in Figure 1 B, iron, the physiological substrate, resulted slightly 
more efficiently transported than cobalt and manganese. With these 
experiments, we have confirmed that rDMT1 transfected oocytes, but 
not non-transfected ones, were able to transport iron, cobalt and 
manganese ions across their plasma membrane. 
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Figure 1 Calcein as a cytoplasmic “metal detector”. A: two electrode 
voltage clamp of a representative rDMT1 transfected oocyte; inward currents 
are induced by 100 µM MnCl2, FeCl2 and CoCl2 (Vh= -40 mV, pH 5.5). B: 
means and standard errors of the transport currents obtained from 40 oocytes, 
five batches. C, D and E: Plots of fluorescence decay (Ft/F0) with corresponding 
images of Calcein-injected oocytes (upper series: non-transfected (NT) and 
lower series: rDMT1 transfected) exposed to 100 µM MnCl2 (C), FeCl2 (D), 
and CoCl2 (E) at pH 5.5 from 3 to 10 oocytes, from 2 to 4 oocytes batches. 
We have, then, filled transfected and not transfected oocytes with 
Calcein and monitored their fluorescence decay with an inverted 
fluorescence microscope. We have controlled that, before Calcein 
injection and at the used wavelengths, oocytes were not fluorescent 
(data not shown). We have also monitored the decay of the fluorescence 
signal in non-transfected Calcein-injected oocytes. Fluorescence 
decreased about 11.8% ± 2.5% in a 30 min interval (Fig. 1 C, D, and E, 
black squares) and, in the pH range 5.5 - 7.6, the decrease was pH-
independent. Therefore, at our experimental conditions, only minimal 
photo-bleaching phenomena occurred. Similarly, non-transfected 
Calcein-injected oocytes which were exposed to 100 µM MnCl2, FeCl2, 
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and CoCl2 (Fig. 1 C, D, and E, squares) underwent a moderate 
fluorescence decay not dissimilar to that occurring in the absence of the 
tested divalent metal ions. 
Fluorescence decay was, instead, evident in transfected oocytes, i.e., in 
oocytes expressing rDMT1. We measured a 31.5% ± 1.1% decay for Mn2+ 
(empty triangles), a 33.2% ± 2.7% decay for Fe2+ (light grey triangles) and 
a 30.4% ± 2.4% for Co2+ (grey triangles). This indicates that the entry of 
the divalent metal ions into the cell caused the quenching of Calcein 
and, consequently, that Calcein can be used to monitor divalent metal 
ion concentration changes in the cytoplasm of Xenopus oocytes. 
In this context, we further investigated metal-Calcein interactions by 
spectrofluorimetry measuring quenching in cuvettes at pH 7.6, close to 
the intracellular value, and at pH 5.5, value at which rDMT1 performs 
optimally. Values at the emission peak wavelength (i.e., 512 nm) were 
recorded for each concentration of Fe2+, Mn2+ and Co2+. The data revealed 
that Calcein quenching is higher for Co2+ and Fe2+, with K0.5 of 7.6 ± 0.7 
and 5.3 ± 0.4 µM at pH 5.5 and 9 ± 3 and 0.9 ± 0.04 µM at pH 7.6. 
Quenching is lower for Mn2+ with a K0.5 of 53.6 ± 27 µM at pH 5.5 and of 
21 ± 5.7 µM at pH 7.6. These spectrofluorometric data confirm that 
Calcein can be used to evaluate changes in the intracellular 
concentration of Mn2+, Fe2+ and Co2+. 
NPs cross the plasma membrane of Xenopus laevis oocytes 
After having verified that we were able to detect an increase of divalent 
metal ions in the cytoplasm of Xenopus oocytes filled with Calcein, we 
have used them to reveal the possible permeation of NPs inside the cell. 
To this aim, we have chosen cobalt NPs in two different forms, metallic 
(Co0) and oxide (Co3O4). Both NP forms undergo dissolution 1,11,34,35 
releasing cobalt ions that can be detected by Calcein quenching. 
Therefore, we have exposed Calcein-filled oocytes to cobalt NPs and, as 
a control, to the corresponding ion. 
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Figure 2. Calcein quenching in oocytes exposed to cobalt NPs. A: 
Representative image series of non-transfected (NT) Calcein-injected oocytes 
exposed to CoCl2 or different cobalt NPs for 0, 10, 20 and 30 min. B: Means of 
the fluorescence decay of 5 to 25 oocytes (obtained from 2 to 5 different batches). 
Decay is expressed as the fluorescence intensity at time 30 min over 
fluorescence intensity at time 0 (F30/F0). Note that quenching is statistically 
significant in NT oocytes exposed to bare Co3O4 NPs and in rDMT1 expressing 
oocytes exposed to CoCl2 (positive control); moreover, the endocytosis blocker 
Dynasore does not change the quenching effect of Co3O4 NPs. Bars are ± SE; 
stars indicate a statistically significant (One-way ANOVA, P<0.05) difference 
with non exposed oocytes. 
In oocytes from different batches, Co3O4 NPs consistently induced a 
quenching of Calcein fluorescence (Fig. 2). This fluorescence decrease, 
although lower than that occurring in rDMT1 expressing oocytes 
exposed to CoCl2 (Fig. 2 B), was significantly higher than that occurring 
in non-transfected oocytes either exposed or not exposed to CoCl2. 
These results suggest that Co3O4 NPs interact with the plasma 
membrane of the oocyte, succeed in crossing it and, once in the 
cytoplasm, their partial dissolution causes the observed quenching 
activity. Indeed, cobalt ions and not NPs are able to interact with Calcein 
and quench its fluorescence. Co NPs, instead, did not cause a reduction 
of fluorescence (Fig. 2 B) suggesting to be unable to pass through the 
plasma membrane of the oocyte. This different behavior of cobalt and 
cobalt oxide NPs could be ascribed to different chemical and physical 
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characteristics of their surfaces. The importance of the surface structure 
of NPs in their interactions with cell membranes has been demonstrated 
comparing membrane penetration of two NPs that were coated with the 
same molecules, but arranged differently 19. In our case, the normal 
spinel structure Co2+ Co23+ O22- of Co3O4 NPs 36 might present a surface 
charge distribution capable to electrostatically interact with the negative 
charges which are present on the plasma membrane surface; indeed, 
Co3O4 NPs firmly bind, through electrostatic interactions, to negatively 
charged biomolecules such as heparin and carboxymethylchitosan 27,28. 
Different cationic NPs have been shown to interact with lipid bilayers 
and cause their disruption 37, cationic gold NPs can enter cells by a non-
endocytotic, energy-independent pathway 16 and cationic polystyrene 
NPs electrostatically interact with lipid bilayers causing deformation 
and poration, while anionic polystyrene NPs do not 14,38. In this context, 
Lin and Alexander-Katz 18, with a coarse-grained simulation, have 
described the dynamics of cationic NP translocation through cell 
membranes and Nolte and colleagues 15 have modelled the transport of 
spherical metal oxide NPs across a lipid bilayer. 
Protein corona impedes plasma membrane crossing 
The importance of the surface characteristics of NPs in their interactions 
with the biological matter is well documented and is cardinal for their 
toxicity as well as for their use in nanomedicine. We have, therefore, 
modified the surface characteristics of Co3O4 NPs by letting them to 
adsorb bovine serum albumin (BSA). This is known to create, around 
the NP, a protein corona, which is capable to modify NP-membrane 
interaction 39,40 as also suggested by computer simulations 17. In our 
experiments, BSA coated Co3O4 NPs (Co3O4 NP@BSA) do not cause 
fluorescence quenching (Fig. 2). 
These results suggest that a “protein corona” effect can prevent or 
significantly reduce the interactions between NPs and the oocyte 
membrane blocking or limiting the passage of NPs into the cytoplasm. 
These findings are in agreement with experiments where the interaction 
of cationic polystirene NPs with artificial lipid bilayers were eliminated 
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with serum proteins 38. Alternatively, rather than impeding NP entry 
into the oocytes, the protein corona could have stabilized NPs against 
dissolution, preventing them, once in the cytoplasm, from releasing 
Calcein-quenching ions. To rule out this possibility, we have performed 
in vitro experiments where NPs, which were previously exposed to BSA, 
were tested for their ability to quench Calcein. Since no significant 
differences were observed, we think that BSA treatment of NPs, 
although capable to generate a protein corona, was not able to prevent 
dissolution. 
Endocytosis does not seem to be responsible of Co3O4 NP entry 
Some of our results could also be explained by endocytosis followed by 
NP escape from the endosomal compartment to the cytoplasm. To 
exclude this possibility, we have used two different approaches: in the 
first one, we have repeated quenching experiments on oocytes treated 
with Dynasore, an endocytosis inhibitor that has been used several 
times to block membrane recycle in Xenopus oocytes41; in the second one, 
we have verified whether or not NP exposure might have elicited 
endocytosis by optical and electron microscopy. 
Dynasore is a cell-permeable molecule that inhibits the GTPase activity 
of dynamin which in turn blocks dynamin-dependent endocytosis 42. 
Quenching experiments were repeated in oocytes that were previously 
incubated for 24 h in 40 µM Dynasore. As shown in Fig. 2 B, there are 
no significant differences in the quenching activity of Co3O4 NPs 
between oocytes that were treated with Dynasore and oocytes that were 
not. 
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Figure 3. Endocytosis is not involved in NP quenching activity. In the 
inset, few fully grown oocytes are visible; note the presence of a pigmented pole 
(denominated animal pole) and of an unpigmented one (denominated vegetal 
pole). After fixation, a spherical cap is hand sliced with a razor blade, placed on 
a glass slide under a coverslip and observed with a 63X oil immersion objective 
from above. A, B, and C: Bright field (left) and the corresponding FITC filter 
(right) images of oocytes exposed to 1 mg/mL Lucifer Yellow CH. (A) control 
oocyte; (B) oocyte exposed to 0.1 mg/mL Co3O4 NPs and (C) oocyte incubated 
24 h with 40 µM Dynasore and exposed to 0.1 mg/mL Co3O4 NPs. In bright 
field images, pigment granules, which are present in the cortex of the oocyte, 
are clearly visible as dark brown dots indicating that we are observing the 
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oocyte animal pole. In the corresponding FITC filter images, no fluorescent 
vesicles are visible indicating no endocytotic activity. 
Dynasore, however, does not halt all the endocytotic routes. Therefore, 
to reveal the possible formation of endocytotic vesicles after NP 
exposure, we have used Lucifer Yellow CH, a water-soluble and 
membrane-impermeable fluorescent dye; it contains a carbohydrazide 
(CH) group that allows it to be covalently linked to the surrounding 
biomolecules by aldehyde fixation. Fully grown oocytes were exposed 
to the tracer dye in presence and in absence of NPs for 30 min, fixed and 
observed under a fluorescence microscope with a 63X oil immersion 
objective. As shown in Figure 3 A, B and C, no fluorescent vesicles are 
visible indicating that there is minimal or no endocytosis in the tested 
conditions. Lucifer Yellow CH had been previously shown to be 
effective in tracing endocytosis occurring immediately after cortical 
granule exocytosis during Xenopus egg fertilization 43,44. Likewise, 
treated samples were prepared also for transmission electron 
microscopy and, notwithstanding a careful observation of the oocyte 
cortex, we could not find any NP carrying endocytotic vesicle among 
the pigment granules and the tightly packed cortical granules which 
characterise the oocyte cortex (data not shown). 
No endogenous divalent metal ion transporters are present on the 
oocyte plasma membrane 
To better characterize our system, and also to rule out possible 
unpredicted artefacts, we have performed further experiments which 
are shown in Figure 4. We have confirmed by electrophysiology that no 
endogenous divalent metal ion transporters are present on the oocyte 
plasma membrane. Indeed, as shown in Figure 4 A, with two electrode 
voltage clamp no currents were recorded in the presence of CoCl2, 
MnCl2; similarly, no currents were recorded also in the presence of 
Co3O4 and Co NPs, which are known to readily dissolve releasing ions. 
This is in agreement with the results shown in Figure 2 where there was 
not fluorescence reduction in non-transfected oocytes placed in solution 
containing CoCl2. 
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Figure 4. Two electrode voltage-clamp of Xenopus oocytes. Inward 
currents elicited by solutions and NP suspensions in NT (A) and rDMT1 
transfected (B, C and D) representative oocytes. Oocytes were clamped at a 
holding potential of -40 mV and exposed to MnCl2 (1) and CoCl2 (2) solutions, 
to Co3O4 (3) and Co (4) NP suspensions and to their surnatants obtained at 
time 0 h (a) and 24 h (b). E: Current mean values (± SE) obtained by 
subtracting from the current in the presence of the substrate, the current in its 
absence and normalizing to the Mn2+ current, a reference for divalent metal 
transporters in electrophysiological studies 6 to 12 oocytes from 4 batches. 
Co, Co3O4 and BSA coated Co3O4 NPs release ions 
Conversely, when rDMT1 transfected oocytes were tested in the 
presence of CoCl2 and MnCl2, inward currents were recorded (Fig. 4 B), 
indicating an electrogenic transport of ions across the plasma 
membrane. Similarly, inward currents were recorded also in the 
presence of Co3O4 and Co NPs, indicating that both NPs, although in a 
different amount, were releasing ions. To confirm the release of Co ions 
from NPs, we have performed a set of experiments (Fig. 4 C and D) 
exposing rDMT1 transfected oocytes to the surnatants of suspensions of 
Co3O4 and Co NPs and obtaining the expected inward currents. 
Moreover, we added BSA exposed NPs to rDMT1 expressing oocytes 
and, in all the tested conditions, we observed a current similar to that 
evoked by the same NPs that were not exposed to BSA (data not shown). 
These data rule out the possibility that BSA might have a role in 
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NPs do not impair oocyte plasma membrane integrity 
To understand whether or not Co3O4 NPs damage oocyte plasma 
membrane, we have measured membrane resistence by two electrode 
voltage clamp. If the NPs damaged the oocyte membrane, we would 
expect a change in membrane permeability and the entrance of Ca2+ ions 
that, in Xenopus oocytes, activate Ca2+-gated chloride channels 45 which, 
at potentials more positive than the chloride reversal potential, give rise 
to an outward current 46. As shown in Figure 5, we applyed a voltage 
ramp to oocytes which were previously exposed to Co3O4 NPs for 30 
min and we did not observe a change in membrane resistance. 
Conversely, after A23187 ionophore addition 45,47, a large chloride 
current appeared, expecially at more positive potentials, due to the 
activation of the Ca2+-gated chloride channels. Therefore, we think that 
NP entry does not cause injury to the plasma membrane. 
 
Figure 5. Measure of membrane resistence of Xenopus oocytes. Ramp 
(from - 85 to + 25 mV) protocols (A) were applied in non transfected oocytes 
starting from the holding potential of -25 mV. Representative currents elicited 
by the protocol in not-exposed oocytes (black line in B), exposed to Co3O4 NP 
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suspensions (red line in C) and perfused with ionophore A23187 (blue line in 
D). Current mean values at -80, -60, -40, -20, 0 and + 20 mV (± SE) obtained 
from at least 12 oocytes (from 2 different batches) are plotted in E. 
In conclusion, we have demonstrated that NPs can cross 
cytomembranes with no evident damage to cell integrity. The canonical 
way of NPs to be uptaken by cells is endocytosis that makes NPs to gain 
access to the endosomal compartment. The NP capability to cross lipid 
bilayers exposes further cellular compartments to NPs. We have learned 
that the capability of Co3O4 NPs to cross the oocyte plasma membrane 
is not paralleled by that of Co NPs and that the crossing of Co3O4 NPs 
can be prevented by a protein corona. Moreover, we have set up a 
system that can be of help in evaluating the effects of different 
functionalizations on NP ability to cross cytomembranes. Finally, we 
have confirmed that Co NPs and, to a less extent, Co3O4 NPs release ions 
in the environment where they are present, i.e., in the extracellular 
solution as well as in the cytoplasm. Dissolution, indeed, is a 
phenomenon one should take into account not only for 
nanotoxicological studies, but also in nanomedicine or in food and feed 
fortification. 
Materials and Methods 
Solutions 
ND96 solution had the following composition (in mM): NaCl 96, KCl 2, 
MgCl2 1, HEPES 5, pH 7.6; modified Barth’s saline (MBS) solution had 
the following composition (in mM): NaCl 88, KCl 1, NaHCO3 2.4, 
HEPES 15, Ca(NO3)2 0.30, CaCl2 0.41, MgSO4 0.82, sodium penicillin 10 
µg/mL, streptomycin sulphate 10 µg/mL, gentamycin sulphate 100 
µg/mL, pH 7.6; external control solution contained (in mM): NaCl 98; 
MgCl2, 1; CaCl2, 1.8, HEPES or MES 5, pH 7.6 or 5.5; intracellular 
solution contained (in mM): KCl 130, NaCl 4, MgCl2 1.6, EGTA 5, HEPES 
10, glucose 5, pH 7.6. The final pH values of 5.5 or 7.6 were adjusted 
with HCl and NaOH. 
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Oocyte collection and preparation 
Oocytes were obtained from adult Xenopus laevis females. Animals were 
anaesthetised in 0.1 % (w/v) MS222 (tricaine methansulfonate) solution 
in tap water and portions of the ovary were removed through an 
incision on the abdomen. The oocytes were treated with 1 mg/mL 
collagenase (Sigma Type IA) in ND96 calcium free for at least 1 h at 18 
°C. Healthy and fully grown oocytes were selected and stored at 18°C 
in MBS solution48. The oocytes to be transfected with the cDNA coding 
for rDMT1 were injected with 25 ng of cRNA in 50 nl of water, the day 
after the removal, using a manual microinjection system (Drummond 
Scientific Company, Broomall, PA) and incubated at 18 °C for 3-4 days 
before electrophysiological or fluorescence experiments. The 
experiments were carried out according to the institutional and national 
ethical guidelines (permit nr. 05/12).  
NP preparation 
Oocytes were exposed to zerovalent (Co, 28 nm, IOLITEC, Salzstrasse 
184, D-74076 Heilbronn) and oxide (Co3O4, < 50 nm TEM determined, 
Sigma-Aldrich) cobalt NPs. 1 mg/mL Stock suspensions were prepared 
in deionised water. 0.1 mL of stock suspension was added to the test 
chamber containing 0.9 mL of external control solution (pH 7.6). 
Suspensions were carefully sonicated before addition to the test 
chamber. 
For dissolution experiments, stock suspensions of Co and Co3O4 NPs 
were prepared to have a 10 mM concentration in terms of cobalt (i.e., 5.9 
mg / 10 mL for Co NPs and 8 mg / 10 mL for Co3O4 NPs). Stock 
suspensions were sonicated for 15 min and 0.5 mL of each suspension 
was added to a Petri dish containing 24.5 mL of deionised water or of 1 
mg/mL BSA to reach a final cobalt concentration of 200 µM. 
After 1 and 24 h, 15 mL were collected from each Petri dish and 
centrifuged for 5 min at 8000 g at 10 °C. The surnatant was transferred 
in a new tube and the procedure was repeated for 4 times. Finally, 8 mL 
of surnatant from the last centrifugation were ultracentrifuged at 300 
000 g at 4 °C for 2 h. The surnatant was collected and filtered (0.22 µm 
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syringe filter). The resulting surnatant was diluted 1:1 in a 2X external 
control solution at pH 5.5 and used in electrophysiological experiments. 
Single Oocyte Fluorescence Assay (SOFA) 
Untransfected oocytes and oocytes transfected with cRNA encoding 
rDMT1 were injected with a 50 nL drop of a 25 µM Calcein in 
intracellular solution. The nominal volume of a 1.2 mm diameter oocyte 
is 1 µL; therefore, a 50 nL injected drop will be diluted 20 times. The 
exact dilution factor is, however, difficult to establish, since not all the 
theoretical volume may be available for free diffusion 49. Following 
Calcein injection, the oocytes were placed in external control solution 
solution at pH 5.5 or 7.6 containing or not, divalent metals at a final 
concentration of 0.1 mM. 
For NP experiments, Co NPs and Co3O4 NPs were added to the testing 
solution to a final concentration of 0.1 mg/mL (pH 7.6). All experiments 
were carried out at room temperature. To block the endocytotic 
pathway, oocytes were incubated in 40 µM Dynasore (Sigma-Aldrich) 
for 24 h before the experiment. 
Images of single oocytes were acquired every 2 min for 30 min with a 
fluorescence microscope (AxioVert 200, Carl Zeiss with a 4x objective, 
COLIBRI fluorescence filters, 470 nm excitation - 515 to 565 nm 
emission) equipped with CCD camera (Axiocam ICM1, Carl Zeiss). 
Fluorescence and transmission electron microscopy 
To assess endocytosis, oocytes were incubated for 30 min in external 
control solution at pH 7.6 with 1 mg/mL Lucifer Yellow CH (Sigma-
Aldrich). Negative controls, oocytes exposed to 0.1 mg/mL Co3O4 NP, 
and oocytes pretreated with Dynasore and exposed to 0.1 mg/mL Co3O4 
NPs were washed 3 times in cold (4°C) external control solution at pH 
7.6 and fixed in 4% paraformaldehyde for two days. Oocytes were 
washed 3 times in cold external control solution, cut in 2 halves which 
were placed on a slide and covered with slips. Samples were observed 
with a fluorescence microscope (Axiophot, Carl Zeiss) with a 63x oil 
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ojective. Bright field and FITC filter images were taken using a CCD 
camera (Discovery C30, TiEsselab). 
For TEM, oocytes were fixed in 4% paraformaldehide and 2% 
glutaraldehide in 0.1 M sodium cacodylate buffer (pH 7.4) for 24h at 4°C 
and stored in 0.1 M sodium cacodylate buffer (pH 7.4) at 4°C. Specimens 
were postfixed in 1% OsO4 in 0.1M sodium cacodylate buffer (pH 7.4), 
dehydrated in ethanol and embedded in Epon-Araldite. For 
ultrastructural studies, thin sections were cut using a Reichert Ultracut-
S-Ultratome ultramicrotome (Leica, Nussloch, Germany), collected on 
300 mesh copper grids, counterstained with uranyl acetate and lead 
citrate and examined under a Jeol 1010 electron microscope operating at 
90 KV (Jeol, Tokyo, Japan). 
Spectrofluorometry 
Calcein quenching by divalent metal ions were measured in external 
control solution at pH 5.5 and 7.6 using a Jasco FP-750 fluorometer with 
excitation at 470 nm. The spectra of 2.5 µM Calcein alone or mixed with 
iron, manganese and cobalt ions at different concentrations were 
acquired in the 490 to 560 nm range. Experiments at pH 7.6 with FeCl2 
were performed in presence of 1 mM ascorbic acid to maintain iron in a 
reduced form. 
Electrophysiology 
The two-electrode voltage-clamp technique was performed with an 
Oocyte Clamp OC-725B (Warner Instruments, Hamden, CT, USA). 
Intracellular glass microelectrodes, filled with 3 M KCl, had tip 
resistances in the 0.5 - 4 MΩ range. Agar bridges (3% agar in 3 M KCl) 
connected the bath electrodes to the experimental chamber. The holding 
potential (Vh) was - 40 mV for the recording of transport currents and -
25 mV for the measurements of membrane resistance. Currents 
associated to membrane transport of divalent ions were recorded in 
oocytes perfused with external control solution at pH 5.5 in the absence 
or in the presence of the indicated divalent metal ions, NPs and NP 
surnatants. To check for the possible presence of membrane damage, 
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the oocyte conductances were tested applying a 1-s long protocol with 
a voltage ramp from - 85 to + 55 mV. Positive controls of membrane 
conductance alteration were obtained perfusing oocytes with 10 µM 
ionophore A-23187 (Sigma-Aldrich). WinWCP version 4.4.6 (J. 
Dempster, University of Strathclyde, UK) or Clampex 10.2 (Molecular 
Devices, Sunnyvale, CA, USA, www.moleculardevices.com) were used 
to run the experiments. 
Data analysis 
Data were analysed using Clampfit 10.2 software (Molecular Devices, 
Sunnyvale, CA, USA, www.moleculardevices.com) while OriginPro 8.0 
(OriginLab Corp., Northampton, MA, USA, www.originlab.com) was 
used for statistics and figure preparation. Transport currents were 
determined by subtracting the records in the absence of a substrate from 
the corresponding ones in its presence. Fluorescence decay images were 
analysed with ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes 
of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-
2015). For Ft/F0 quantification, the fluorescence intensity at time 0 (F0) 
and at subsequent times (Ft) was calculated in the entire area of the 
oocyte. 
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Abstract 
Iron deficiency is a major global public health problem despite decades 
of efforts with iron supplementation and fortification. The issue lies on 
the poor tolerability of the standard of care soluble iron salts, leading to 
non-compliance and ineffective correction of iron-deficiency anaemia. 
Iron nanoformulations have been proposed to fortify food and feed to 
address these issues. Since it was just postulated that some 
nanoparticles (NPs) might cross the plasma membrane also by a non-
endocytotic pathway gaining direct access to the cytoplasm, we have 
studied iron NP uptake under this perspective. To this aim, we have 
used a recently tested protocol that has proven to be capable of 
following the cytoplasmic changes of iron concentration dynamics and 
we have demonstrated that iron oxide NPs, but not zerovalent iron NPs 
nor iron oxide NPs that were surrounded by a protein corona, can cross 
plasma membranes. By electrophysiology, we have also shown that a 
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small and transient increase of membrane conductance parallels NP 
crossing of plasma membrane. 
Introduction 
Iron deficiency is a major global public health problem, common in 
adolescence, in menstruating women and in elderly, and particularly 
evident in developing countries. In addition, several diseases cause iron 
deficiency, including intestinal parasite infections, malaria, gastric and 
duodenal ulcers, gastrointestinal cancer and rare mutations in genes 
encoding ion transporters1,2. Iron deficiency can be efficaciously 
controlled by iron supplementation or food fortification. Unfortunately, 
the water-soluble and bioavailable ferrous sulphate, fumarate or 
gluconate, that are currently used therapeutically, affect the 
gastrointestinal tract with significant side effects such as constipation, 
diarrhoea and nausea3; moreover, iron salts cause unacceptable changes 
in the colour and taste of foods4. In contrast, poorly water-soluble 
compounds cause fewer sensory changes, but present limited 
bioavailability. Recently, the use of NPs in iron supplementation and 
fortification has been suggested since their use may combine high 
bioavailability, good product stability, limited side effects and absence 
of changes of taste and colour of the fortified foods5-8. Moreover, in vitro 
and in vivo experiments have shown that iron NPs can be considered 
safe9,10. Nanoformulations have also found their way into the 
fortification of animal feeds11-13. Ferritin, which is well absorbed14, is 
itself composed of an iron oxide nanocore surrounded by a protein shell 
and, recently, a nanoparticulate mimetic of the ferritin core was 
proposed as a potentially side effect-free form of cheap supplemental 
iron15. 
In the gut lumen, dietary iron is present as heme and non-heme 
(inorganic) iron; inorganic iron can be found in two oxidation states: 
ferrous (Fe2+) iron and, predominantly, as ferric (Fe3+) iron. Ferric iron is 
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reduced to ferrous iron by duodenal cytochrome b, an enzyme present 
on the plasma membrane of the enterocyte brush border; Fe2+ is 
eventually transported into the cytoplasm by means of the divalent 
metal transporter DMT11,16 Nanoparticulate iron might follow a 
different route to access enterocyte cytoplasm. Powell and 
colleagues15,17-19 have suggested that nanoparticulate iron, like ferritin20, 
enters cells by endocytosis reaching the cytoplasm by lysosomal escape. 
Endocytosis is, indeed, the canonical mechanism by which NPs are 
known to be up-taken21, but it might not be the only one. The work on 
ferritin core mimetics focused on highly disperse NPs with an outer 
layer of charged short-chain carboxylates15, however, poorly charged or 
‘naked’ (i.e. lacking an outer coating) NPs may behave differently. In 
effect, it has been recently postulated that some metal NPs might also 
cross the plasma membrane by a non-endocytotic pathway22-28 gaining 
a direct access to the cytoplasm. Indeed, we have recently confirmed 
this pathway for cobalt oxide NPs. This pathway, which involves 
perforation of the lipid bilayer, is usually poorly considered and 
challenges the idea of non-permeability of membranes to hydrophilic 
molecules or supramolecular structures. 
To verify this possibility, we have studied commercially available iron 
based NPs that do not comprise a dispersing outer layer. We have 
characterized their size and surface charge and, through a recently 
developed protocol, we have followed the cytoplasmic concentration 
dynamics of iron, demonstrating that iron oxide NPs, but not zerovalent 
iron NPs, were up-taken. We have also shown that the NP crossing of 
the plasma membrane is accompanied by a transient increase of 
membrane conductance, but this crossing did not occur when the iron 
oxide NPs were aggregated or surrounded by a protein corona. 
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Results and Discussion 
Calcein and Xenopus laevis oocytes for monitoring intracellular iron 
increase 
As a preliminary step, we have tested the ability of Calcein to detect 
intracellular iron concentration increase in fully-grown Xenopus laevis 
oocytes. Fully-grown oocytes are large cells arrested at prophase of 
meiosis I, which provide a simple system for the study of membrane 
transport. Calcein is a divalent metal ion chelating fluorochrome whose 
fluorescence, at physiological pH, is strongly quenched by cobalt, 
nickel, copper, iron and manganese divalent cations. 
To this aim, we have prepared transfected Xenopus oocytes expressing 
the Divalent Metal ion Transporter 1 from rat (rDMT1). This membrane 
protein is a proton dependent transporter of divalent metal ions such as 
Fe2+, Mn2+, Co2+, Ni2+ and Cd2+ 29-32. We have performed voltage-clamp 
experiments in transfected (i.e., injected with DMT1 cRNA) and in non-
transfected (control) oocytes exposed to FeCl2, both at pH 5.5 and 7.6. 
We have calculated transport currents as the difference between the 
currents recorded in the presence and in the absence of 100 µM FeCl2 in 
the external solution. As shown by the current-voltage (I-V) relationship 
(Figure 1A), no transport currents were recorded in non-transfected 
(control) oocytes when exposed to iron ions confirming the absence of 
endogenous electrogenic Fe2+ transporters in the oocyte plasma 
membrane. Conversely, in rDMT1 transfected oocytes, at pH 5.5, but 
not at pH 7.6, the presence of FeCl2 in the extracellular solution elicited 
large inward currents at negative potentials. This indicates that, at pH 
5.5, a transmembrane transport of iron ions occurs in rDMT1 transfected 
oocytes. 
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Figure 1: Calcein as iron detector. A) Current-voltage (I-V) relationships of 
Non-Transfected (NT) oocytes and DMT1-expressing oocytes at pH 5.5 and 
7.6; note that only DMT1-transfected oocytes at pH 5.5 are able to transport 
iron ions causing large inward currents. B) Calcein quenching is plotted versus 
time as the ratio of the fluorescence (FI) and the fluorescence recorded at time 0 
(F0); again only DMT1-transfected oocytes at pH 5.5 are able to transport iron 
ions causing the increase of their intracellular concentration. C) Representative 
images of oocytes injected with Calcein and increasing amount of iron ions to 
obtain the standard curve of panel D. D) The mean values of fluorescence, 
normalized to the mean values of fluorescence measured in oocytes injected with 
Calcein alone are plotted versus intracellular iron concentration; (from 60 to 
80 from 3 batches for each concentration) of oocytes for each iron 
concentrations; data were fitted with a logistic curve (K0.5 = 3.97 ± 2.09 µM). 
We repeated the same experimental plan in oocytes previously injected 
with Calcein (25 µM) to demonstrate that Calcein was able to detect an 
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intracellular increase of Fe2+ concentration. As shown in Figure 1B, we 
monitored the reduction of Calcein fluorescence for 30 min in 
transfected and in non-transfected oocytes exposed to 100 µM FeCl2 at 
pH 5.5 and 7.6. The results clearly show that a significant quenching of 
the fluorescence occurred only in DMT1 expressing oocytes at pH 5.5. It 
has to be noted that in DMT1 expressing oocytes at pH 7.6 no current 
(Figure 1A) and no Calcein quenching (Figure 1B) was recorded, 
according to the transporter pH dependence. These experiments, taken 
together, demonstrate that Calcein can detect an increase in the 
concentration of intracellular iron ions, and that oocytes are devoid of 
endogenous iron transporters. 
To define the sensitivity of the method, we have injected oocytes with a 
fixed amount of Calcein together with increasing amounts of FeCl2. We 
have then measured the residual fluorescence for each iron 
concentration and we have recorded a dose dependent reduction of the 
emission values (Figure 1C) that we have fitted with a logistic equation 
(Figure 1D). Given an oocyte volume of about 1 µl, the K0,5 resulted 3.97 
± 2.09 (SE) µM. By means of this curve, we can estimate the 
concentrations of iron ions in the cytoplasm of Xenopus oocytes. Indeed, 
Figure 1B shows that DMT1 transfected oocytes reach, 30 min after 
exposure to FeCl2, quenching values corresponding to concentrations of 
about the 5 µM. 
After 30 min of exposure of Xenopus oocytes to radioactive iron, 
Marciani and colleagues33 reported concentrations slightly higher. Their 
experimental approach based on radioactive 55Fe2+, however, considered 
the total amount of iron that entered the cytoplasm through DMT1. 
Since a large amount of iron might become protein-bound, they 
estimated the total concentration of the iron ions. 
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Iron oxide NPs cross the plasma membrane of Xenopus laevis 
oocytes 
After having verified that we were able to detect an increase of iron ions 
in the cytoplasm of Xenopus oocytes that were filled with Calcein, we 
have used them to reveal the possible permeation of iron NPs inside the 
cell. To this aim, we have chosen iron NPs in two different forms, 
zerovalent (Fe) and oxide (Fe3O4). Similarly to other metal NPs10,21,34, 
iron35 and iron oxide36,37 NPs undergo dissolution releasing iron ions 
that, as we have here demonstrated, can be detected by Calcein 
quenching. As such, we exposed Calcein-filled oocytes to iron NPs. In 
oocytes obtained from different batches, iron oxide NPs constantly 
induced a quenching of Calcein fluorescence (Figure 2, blue column). 
This fluorescence decrease, although lower than that occurring in 
rDMT1 expressing oocytes exposed to 100 µM FeCl2 (Figure 2, dark blue 
column), was significantly greater than that occurring in non-
transfected oocytes either exposed (Figure 1B, black squares) or not 
exposed (Figure 1B, white diamond and Figure 2, white bar) to FeCl2. 
These results suggest that Fe3O4 NPs interact with the plasma 
membrane of the oocyte, cross it and, once in the cytoplasm, dissolve 
causing the observed Calcein quenching. Zerovalent iron NPs, instead, 
did not cause a reduction of fluorescence (Figure 2, dark cyan column) 
suggesting that, in this case, NPs do not cross the plasma membrane of 
the oocyte. 
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Figure 2: Iron oxide NPs induce intracellular iron increase. Histogram of 
the means of the F30/F0 values calculated as the fluorescence values at time 30 
min normalized for the fluorescence values at time 0. Fe3O4 NPs (blue column) 
caused a statistically significant quenching of Calcein compared to the controls, 
i.e., Calcein injected oocytes exposed to external control solution at pH 7.6 
(white column). Conversely, Fe NPs (green column), aggregated Fe3O4 NPs 
(blue barred column) and BSA modified Fe3O4 NPs (cyan column) did not 
induce quenching; rDMT1 transfected oocytes exposed to iron chloride were 
used as positive controls (dark blue column). Bars represent ± SEM; from 10 to 
40 oocytes for each column deriving from 2 to 8 batches were used. Statistical 
analysis was performed with One-way ANOVA and orthogonal comparisons 
with Holm-Bonferroni post hoc test (***=p<0.005).  
In a previous paper, we attributed the different biological behaviour 
(capacity to cross cell membranes) between metal oxide and zerovalent 
metal NPs to the chemical and physical characteristics of their surfaces. 
To better understand the causes of these differences, in this paper, we 
have measured z-potentials and described the aggregation dynamics of 
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electrophoresis (Figure 3, top), were -5.0 ±0.2 mV and -2.2 ± 0.1 mV for 
zerovalent iron and iron oxide NPs, respectively. Thus, both types of 
NPs are poorly charged when suspended in external control solution 
and this does not explain the difference in capacity to cross cell 
membranes, but explains why both NPs rapidly aggregate into 
micronized assemblies when added to media (Figure 3, bottom) despite 
prior ultrasonication. Indeed, z-potentials above 30 mV or below -30 mV 
are generally required to maintain NPs disperse in solution through 
electrostatic repulsion. However, the rate of aggregation, as determined 
by Static Light Scattering (Figure 3, bottom), differed between 
zerovalent NPs, which aggregated very rapidly, and iron oxide NPs, 
which retained a sub-micron population for at least 5 min (Figure 3, 
insets of bottom graphs).  
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Figure 3: Characterisation charge and hydrodynamic size of zerovalent 
iron (Fe0) and iron oxide (Fe3O4) NPs in external control solution (0.1 
mg/mL). Zeta potential (top graphs) was determined by Laser Doppler Micro-
electrophoresis as -5.0 ± 0.2 mV and -2.2 ± 0.1 mV for zerovalent iron and iron 
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oxide NPs, respectively (N=3). Hydrodynamic size was determined over time 
by Static Light Scattering (bottom graphs). 
We think that the NPs that constitute this sub-micron population are 
those that can cross the plasma membrane possibly because these 
remained below a not yet determined upper particle size limit for 
plasma permeation. Physical penetration of lipid bilayer membranes by 
NPs has been demonstrated to possibly occur by dissipative particle 
dynamics simulations for single NPs and for very small clusters. 
Aggregated NPs, instead, are likely too large to penetrate the lipid 
bilayer28. Indeed, when the oocytes were exposed to aggregated NPs, 
we did not record Calcein quenching (Figure 2, blue barred column). 
NPs do not impair oocyte plasma membrane integrity, but open a 
transient conductance 
To learn more about the interactions of NPs with the plasma membrane 
of the oocytes, we have followed possible changes of its integrity due to 
exposure to Fe3O4 NPs by Two Electrodes Voltage Clamp (TEVC). With 
a similar approach, Bernareggi and colleagues38 have recently evaluated 
the effects of asbestos fibres on Xenopus oocyte membrane. 
We have measured membrane capacitance, resting potential and 
resistance during a 30 min period of exposure to Fe3O4 NPs. Since we 
have noticed that the alterations of membrane parameters occur within 
the first 5 min, we have decided to perform the electrophysiological 
measurements after 5 and 20 min of exposure; we have also exposed 
oocytes to NPs that, after sonication, were left undisturbed for 30 min. 
A statistically significant decrease of membrane resistance, as shown in 
Figure 4, occurs only in oocytes exposed for 5 min and disappears 
completely in oocytes exposed for 20 min. A slight decrease of resting 
potential, statistically significant, accompanied the decrease of 
membrane resistance. Membrane capacitance, instead, remained 
unaffected by Fe3O4 NPs treatment. 
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Figure 4: Effects of Fe3O4 NPs on oocyte membrane electrical properties. 
Mean values of membrane electrical parameters registered from oocytes exposed 
to control conditions (white columns), to a Fe3O4 NP suspension for 5 min (blue 
columns) or for more than 20 min (green columns), and to NPs that after 
sonication, were left undisturbed for 30 min, blue barred columns). Membrane 
capacitance of control and treated oocytes showed no significant differences at 
any incubation times. Resting potential and Membrane resistance significantly 
diminishes in oocytes treated 5 min with Fe3O4 NPs compared to their controls; 
the difference disappears in oocytes treated for 20 min and in oocyte treated 
with aggregated NPS. Bars represent mean ± SEM; 14 to 30 oocytes from 2 
oocyte batches were used. Statistical analysis was performed with one-way 
ANOVA and orthogonal comparisons with Holm-Bonferroni post hoc test 
(*=p<0.05 - **=p<0.01). 
The decrease of membrane resistance can be attributed to the opening 
of a small transient conductance. On the other hand, the constancy of 
membrane capacitance is an indication that no large endocytosis 
phenomena occur after exposure to iron oxide NPs39, while the small 
reduction of the resting potential proves that the membrane has 
maintained its integrity40, notwithstanding a small increase of ion 
permeability. 
To investigate further this transient conductance, we have performed a 
protocol to obtain I-V curves. Figure 5A shows representative current 
traces recorded after imposing voltage steps in a control oocyte and in 
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average currents at each potential and reported these data in the I-V 
curves of Figure 5D.  
 
Figure 5: Membrane currents recorded in oocyte exposed or not to Fe3O4 
NPs. A) Voltage Protocol: from holding potential of -40 mV, 10 mV steps of 1 
s were applied from -80 mV to +50 mV. Representative traces recorded from 
oocytes not exposed (B) or (C) exposed for 5 min to Fe3O4 NPs. In D, the 
averages of steady state membrane currents are reported as I-V relationships. 
After 5 min of NP exposure (blue circles), a slight, but statistically significant 
current increase is recorded at the curve extremes; after 20 min (blue triangles), 
no more statistically significant differences can be appreciated. Aggregated NP 
treatment generated in oocytes currents (red diamonds) almost overlapping 
with controls (black squares) and 20 min treatment currents, and that is an 
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indication of the inefficacy of this treatment (*=p<0.05, ***=p<0.005; one-way 
ANOVA, Holm-Bonferroni post hoc orthogonal comparison; 14 to 30 oocytes 
from 2 batches). 
At potentials more negative than -40 mV and more positive than +30 
mV, a slight increase of the currents obtained in exposed oocytes, 
compared to those in the control condition, is evident. This current 
increase is statistically significant only in oocytes tested within 5 min of 
the NPs treatment and it tends to disappear in oocytes exposed for more 
than 20 min and is not present in oocytes exposed to NPs that, after 
sonication, were left undisturbed for 30 min. The I-V curves confirm the 
onset of a conductance caused by the exposure to Fe3O4 NPs for 5 min 
and its transient nature. 
Protein corona impedes plasma membrane crossing and the opening 
of the transient conductance 
To verify our hypothesis concerning the role of the interactions between 
NPs and plasma membrane, we tested uptake of Fe3O4 NPs in bovine 
serum albumin (BSA) containing media. These molecules create a 
coating around the NPs, referred to as protein corona. This corona is 
highly dynamic and its formation and stability depends on NP 
characteristics and environmental variables41. BSA is negatively charged 
in water, but not in this media (Supp Figure S1) presumably due to the 
presence of positively charged calcium and magnesium ions. 
Consequently, the addition of BSA did not alter the surface charge of 
the iron oxide NPs (zeta potential was -1.3 ± 0.2 mV; Figure 6 top).  
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Figure 6: Zeta potential distribution (top) and particle size distribution 
over time (bottom) of a suspension of Fe3O4 NPs (0.1 mg/mL) in external 
control solution with 1 mg/mL BSA. Zeta potential was determined by 
Laser Doppler Micro-electrophoresis as -1.3 ± 0.2 mV (N=4). 
However, the addition of BSA did increase dispersibility as determined 
by the presence of the sub-micron fraction for the duration of the assay 
(Figure 6). As shown above, plasma membrane crossing occurs in the 
presence of disperse colloids; however, exposure to BSA-coated Fe3O4 
NPs did not cause fluorescence quenching (Figure 2, cyan column). 
Therefore, protein corona prevents or significantly reduces the 
interactions between NPs and the oocyte plasma membrane blocking or 
limiting the passage of NPs into the cytoplasm. These findings are also 
in agreement with experiments where the interaction of cationic 
polystyrene NPs with artificial lipid bilayers were eliminated with 
serum proteins 42.  
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To confirm this hypothesis, we have performed TEVC experiments to 
obtain I-V curves (Figure 7).  
 
Figure 7: Protein corona affects NP capacity to elicit membrane 
currents. I-V relationships of control oocytes and oocytes treated for 5 min with 
BSA are compared in the left panel and no statistically significant differences 
are present, indicating that BSA does not affect per se membrane resistance. In 
the central panel, it is shown that Fe3O4 NPs that were coated with a BSA 
corona do not cause a decrease of the membrane resistance suspension. In the 
right panel, the I-V relationships of oocytes treated for 5 min with Fe3O4 NPs 
and BSA coated Fe3O4 NPs are compared. Their difference is statistically 
significant, indicating that the presence of a protein corona around Fe3O4 NPs 
diminishes their capacity to elicit membrane currents. Statistical analysis was 
performed with one-way ANOVA and orthogonal comparisons with Holm-
Bonferroni post hoc test (*=p<0.05); 27 to 61 oocytes for each condition from 3 
to 4 batches were used. 
After having verified that BSA per se does not affect membrane 
conductance, we have compared oocytes exposed to BSA-modified 
Fe3O4 NPs with unexposed oocytes, and to oocytes exposed to Fe3O4 
NPs. These experiments suggest that, when NPs are surrounded by a 
protein corona, they become unable to modify membrane resistance. 
Conclusions 
In conclusion, we have added further evidence to the possibility of 
cytomembranes being permeable to uncoated NPs. Endocytosis is the 
typical mechanism cells use to uptake NPs that, in this way, gain access 
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to the endosomal compartment. Conversely, by directly crossing lipid 
bilayers, NPs enter cytoplasm and other cellular compartments. 
Moreover, we have shown that the penetration by NPs of the lipid 
bilayer opens a transient conductance that does not impair plasma 
membrane integrity. 
Whether we should favour NP presence in the cytoplasm or avoid it, we 
have to understand the mechanisms that regulate their uptake and 
consider how physicochemical properties of NPs impact on their fate. 
In this work, we have also learned that, unlike iron oxide NPs, 
zerovalent iron NPs do not cross plasma membranes. We have 
explained this different behaviour with the very fast aggregation rate of 
zerovalent iron NPs. In addition, we have shown that the crossing of 
metal oxide NPs can be impeded by a protein corona. Indeed, proteins 
are abundant in the tissue fluids, but NPs could be functionalized to 
become corona-free43, thus potentially enabling the non-endocytic 
pathway. For example, superparamagnetic iron oxide NPs can be 
induced to rotate around their axes by a remote magnetic field44 and 
have been used to kill cancer cells through mechanical rupture45. 
Understanding the mechanisms that regulate NP uptake or their 
interactions with the cellular membrane could help in potentiating the 
anticancer properties of such NPs. 
We also understand that the conditions iron NPs find in the 
gastrointestinal tract greatly differ from those of the simple model 
system we have used. In particular, the intestinal millieu comprises a 
diverse group of soluble species, ranging from small carboxylates 
throught bile acids to high molecular weight mucins46-48, many of which 
may interact with the surface of uncoated NPs and, in doing so, may 
alter their behaviour. This now merits assessment in future studies 
using conditions that are representative of the complex gastrointestinal 
environment. 
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Materials and Methods 
Solutions 
ND96 solution had the following composition (in mM): NaCl 96, KCl 2, 
CaCl2 1.8, MgCl2 1, HEPES 5, pH 7.6; NDE solution was composed of 
ND96 plus 2.5mM pyruvate and 50 µg/mL Gentamycin sulphate; 
external control solution contained (in mM): NaCl 98; MgCl2, 1; CaCl2, 
1.8, HEPES or MES 5, pH 7.6 or 5.5; intracellular solution contained (in 
mM): KCl 130, NaCl 4, MgCl2 1.6, EGTA 5, HEPES 10, glucose 5, pH 7.6. 
The final pH values of 5.5 or 7.6 were adjusted with HCl and NaOH. 
Oocytes collection and preparation 
Oocytes were obtained from adult Xenopus laevis females. Animals were 
anaesthetised in 0.1 % (w/v) MS222 (tricaine methansulfonate) solution 
in tap water; after carefully cleaning the frog abdomen with an 
antiseptic agent (Povidone-iodine 10%)49, laparotomy was performed 
and portions of the ovary were collected. The oocytes were treated with 
0,5 mg/mL collagenase (Sigma Type IA) in ND96 calcium free for at least 
30 min at 18 °C. Healthy and fully grown oocytes were selected and 
stored at 18°C in NDE solution50. The oocytes to be transfected with the 
cRNA coding for rDMT1 were injected with 25 ng of cRNA in 50 nL of 
water, the day after the removal, using a manual microinjection system 
(Drummond Scientific Company, Broomall, PA) and incubated at 18 °C 
for 3-4 days before electrophysiological or fluorescence experiments. 
The experimental protocol was approved locally by the Committee of 
the “Organismo Preposto al Benessere degli Animali” of the University 
of Insubria (OPBA-permit #02_15) and nationally by Ministero della 
Salute (permit nr. 1011/2015). 
NP preparation and incubation conditions 
Zerovalent (Fe, 25 nm, IOLITEC, Salzstrasse 184, D-74076 Heilbronn) 
and oxide (Fe3O4, < 50 nm TEM determined, Sigma-Aldrich) iron NPs 
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were prepared as 10 mg/mL stock suspensions in deionised water and 
sonicated before addition of 10 µL to the test chamber (4 wells plate) 
containing 990 µL of external control solution (pH 7.6). Oocytes were 
then added to the chamber. 
For electrophysiological experiments, the oocytes were transferred to 
the TEVC recording chamber within 5 min or after 20 min from the 
beginning of the exposure. For the fluorescence assay, recordings start 
immediately after oocytes addition to the test chamber. Treatments with 
the aggregated NPs were performed adding oocytes to the suspension 
of NPs that were let to aggregate in the test chamber for 30 min after 
sonication. 
All experiments were carried out at room temperature. 
Fluorescence Assay 
Oocytes were injected with a 50 nL drop of intracellular solution 
containing 25 µM Calcein. In dose-response evaluation experiments 
(Fig. 1C and D), solutions containing Calcein and increasing amounts of 
FeCl2 were co-injected in oocytes. Effective intracellular metal 
concentrations were calculated using the nominal oocyte volume of 1 
µL51. Images were acquired for every oocyte at fixed acquisition 
parameters, calculated on control oocytes. 
In experiments with NPs, images of single oocytes were acquired every 
2 min for 30 min with a fluorescence microscope (AxioVert 200, Carl 
Zeiss with a 4x objective, COLIBRI fluorescence filters, 470 nm 
excitation - 515 to 565 nm emission) equipped with CCD camera 
(Axiocam ICM1, Carl Zeiss). 
Electrophysiology 
The two-electrode voltage clamp was performed with an Oocyte Clamp 
OC-725B (Warner Instruments, Hamden, CT, USA) that was controlled 
by Clampex 10.2 (Molecular Devices, Sunnyvale, CA, USA, 
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www.moleculardevices.com). Intracellular glass microelectrodes, filled 
with 3 M KCl, had tip resistances in the 0.5 - 4 MΩ range. Agar bridges 
(3% agar in 3 M KCl) connected the bath electrodes to the experimental 
chamber. The holding potential applied (Vh) was -40 mV for all the 
experiments performed. The I-V curves of Figure 1A were obtained 
applying 20 mV steps of 200 ms from -140 to + 40 mV. 
Oocytes were transferred in the recording chamber (Warner- RC-1Z) 
(warneronline.com) and impaled with microelectrodes; to recover from 
possible damage they were left for 2 min in a continuous solution flux. 
Only oocytes with resting potential equal or lower than -20 mV were 
used for the experiments. The number of discarded oocytes was not 
significantly different between treated and controls. 
The capacitance and resistance values that were reported in Figure 4 
were obtained applying 10 mV steps of 20 ms every 200 ms in voltage 
clamp conditions. The protocol for the I-V curves of Figure 1 was 
previously described52 and for Figures 5 and 7 is shown in Figure 5A (10 
mV steps of 750 ms from -80 to +40 mV). 
Data analysis 
Data were analysed using Clampfit 10.2 software (Molecular Devices, 
Sunnyvale, CA, USA, www.moleculardevices.com) while OriginPro 8.0 
(OriginLab Corp., Northampton, MA, USA, www.originlab.com) was 
used for statistics and figure preparation. For the Voltage Step protocol, 
current values were measured for every voltage step at the steady state 
condition; mean values at every voltage were calculated and plotted. 
Fluorescence decay images were analysed with ImageJ (Rasband, W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2015). For F30/F0 quantification, the 
fluorescence intensity at time 0 (F0) and at time 30 min (Ft) was 
calculated in the entire area of the oocyte. In dose-response experiments, 
images were analysed calculating fluorescence intensity on the entire 
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area of oocytes and normalized to the control oocytes. Mean values were 
calculated for every condition and used to determine through a non-
linear fitting (Logistic Fitting, OriginPro8) the K0.5, relating residual 
fluorescence to metal concentration. 
Static light scattering (SLS) 
SLS was performed on a Mastersizer 2000 with a Hydro 2000µP Micro 
Precision sample dispersion unit (Malvern Instruments Limited). 
Baseline correction was carried out with fresh external control solution 
(prepared as described above). Next, 200 µL of 10 mg/mL stock 
suspension was added to the 20mL dispersion cell to achieve a final 
concentration of 0.1 mg/mL (as per Oocyte assays). The dispersion unit 
was run at 1000 rpm and care was taken to prevent bubble formation. 
The stock suspension was carefully sonicated prior to introduction to 
the dispersion cell, after which data acquisition was immediately 
initiated. Size measurements then were carried out over a period of 60 
min (refractive index: 2.42; absorption 1.0; dispersant refractive index: 
1.33). 
Zeta potential 
The zeta potential of suspensions of iron NPs was determined by Laser 
Doppler Micro-electrophoresis (Zetasizer NanoZS, Malvern 
Instruments Ltd) using disposable folded capillary cells (DTS1070). 
Measurements (N=3) were carried out using the diffusion barrier as per 
instrument manufacturer instructions. Briefly, the zeta cell was filled 
with 1 mM NaCl solution and then 100 µL sample (0.1 mg/mL 
suspension of NPs in external control solution) was gently injected to 
the bottom of the cell with a gel-loading tip. Electrophoretic mobility of 
particles was converted into zeta potentials by Dispersion Technology 
Software 7.11 using the Smoluchowski approximation, and a viscosity 
of 0.8872cP and dielectric constant of 78.5 for the dispersant. 
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Figure S1. Zeta potential distribution of a BSA solution (40 mg/mL) in 
external control solution (Top; N=2) and in water (Bottom, n=3).  
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Abstract 
The risk of exposure to metal nanoparticles (NPs) has increased with 
their widespread use in industry, research and medicine. It is well 
known that NPs may enter cells and that this mechanism is crucial to 
exert both the therapeutic and toxicity effects. The main cellular 
entrance route is endocytosis-based that leads to the entrapment of the 
internalized particles in the endosomal-lysosomal compartment. 
However, recent experimental studies, have reported that NPs (surface-
modified or not) can also enter the cell crossing directly the plasma 
membrane. It is thus important to investigate on this alternative 
internalization mechanisms to increase the comprehension of possible 
NP-related cell toxicity. We have demonstrated that a direct permeation 
of metal oxide NPs through the lipid bilayer of the cell membrane can 
occur, giving direct access to the cytoplasm. 
In this paper, using the powerful tool of Xenopus laevis oocytes and two 
electrode Voltage Clamp, we have investigated several parameters that 
can influence the direct crossing. The most significant of them is the NP 
hydrodynamic size as clearly shown by the comparison of the 
behaviour between Co3O4 and NiO NPs. By collecting biophysical 
membrane parameters in different conditions, we have shown that NPs 
that are able to cross the membrane share the ability to maintain a 
hydrodynamic size lower than 200 nm. The presence of this route of 
entrance must be considered for a better comprehension of the 
mechanism of nanotoxicity and for a safe design of engineered NPs. 
Furthermore, NPs-membrane interaction studies conducted with 
Xenopus laevis oocytes proved the value of this platform to study the 
effects of NPs on the membrane physiology. 
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Introduction 
The risk of exposure to nanoparticles (NPs) has increased with their 
widespread use in industry, research and medicine (Amde et al., 2017, 
Bhuvaneshwari et al., 2017). In most of the therapeutic applications, it is 
mandatory for NPs to enter the cell and reach the intracellular milieu, 
whereas this is considered a risk when NPs are harmful.  
The main cellular entrance routes are endocytosis based, and usually 
these require a trigger to be activated (Bannunah et al., 2014, Date et al., 
2016). However, recent experimental studies, have reported that NPs 
(surface-modified or not) can also enter the cell crossing directly the 
plasma membrane (Nativo et al., 2008, Chen et al., 2009, Brandenberger 
et al., 2010, Lin and Alexander-Katz, 2013, Bossi et al., 2016, Li et al., 2017, 
Zanella et al., 2017). This route could overcome some of the limitations 
related to endocytosis, giving direct access to the cytoplasm and, from 
there, to the intracellular organelles such as nuclei and mitochondria. It 
is thus important to investigate this alternative internalization 
mechanisms to increase the comprehension of possible NP-related cell 
toxicity.  
It is known that size, surface chemistry, solubility and shape play a role 
in NP ability of entering the cell (Peters et al., 2006, Cho et al., 2010, 
Frohlich, 2012, Alkhammash et al., 2015, Beddoes et al., 2015, Anders et 
al., 2018), but it is still to be elucidated how these properties act on cell 
membrane. Data from simulations, like molecular dynamics, may serve 
the purpose (Song et al., 2012, Ding and Ma, 2015, Li et al., 2015, Zhang 
et al., 2015, Shimizu et al., 2016), but experimental evidence is always 
needed to confirm simulation results. To collect data, the main 
approaches used were those based on cell cultures, liposomes or 
artificial membranes (Peetla and Labhasetwar, 2009, Moghadam et al., 
2012, Alkhammash et al., 2015), together with fluorescent dyes able to 
detect the leakage of cytosolic components out of the cell or of 
extracellular component into cells. However, biophysical membrane 
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parameters were seldom considered. Shin and co-workers (Shin et al., 
2013) investigated the role of membrane potential in the interaction of 
the cell with charged NPs, demonstrating that anionic NPs, but not 
cationic, are influenced by cell potential in their interaction with plasma 
membranes. Arvizo and co-workers (Arvizo et al., 2010) considered the 
effect of differently functionalized gold NPs on membrane potential by 
real-time fluorescence microscopy and voltage-sensitive fluorescent 
probes, while Warren and co-workers (Warren and Payne, 2015) studied 
the effect of differently functionalized polystyrene NPs on cell potential 
mainly through flow cytometry and fluorescent microscopy. However, 
none of these papers provide a direct measurement of membrane 
potential, as done by Chen and co-workers (Chen et al., 2009) who, by 
patch clamp, recorded the effects caused by the direct access of cationic 
NPs to the cytoplasm. 
In this paper, we have focused our attention on cobalt- and nickel-based 
NPs since these metals lead to cytotoxic effects that, in some cases, are 
caused by their degradation products (Horev-Azaria et al., 2011, 
Frohlich, 2013, Ortega et al., 2014, Sabbioni et al., 2014a, Sabbioni et al., 
2014b, Ansari et al., 2017). Nickel-based NPs induce respiratory 
pathologies in humans and oxidative stress in cellular models and in in 
vivo experiments (Horie et al., 2011, Morimoto et al., 2011, Ahamed et al., 
2013, Horie et al., 2016). To define the characteristics that allow NPs to 
directly cross the membrane, we have measured membrane biophysical 
parameters of Xenopus laevis oocytes before and after exposure. Our data 
suggest a correlation between NP characteristics and resting potential, 
membrane resistance and current-voltage relationship. Particularly, the 
NP aggregation state emerged as one of the most important parameters 
to be considered for determining the ability of NPs of membrane direct 
crossing. 
  




Figure 1: Effects of cobalt based NPs on plasma membrane. Membrane 
capacitance, resting potential, membrane resistance, and membrane currents in 
oocytes treated with Co-based NPs. Histograms report membrane capacitance 
in A, resting potential in B and membrane resistance in C, measured from 
oocytes treated with 0.1 mg/ml of NPs in buffered solution, as indicated in 
Materials and Methods. In D, current voltage relationships (I/V) were 
determined for each condition applying the voltage pulse protocol described in 
Materials and Methods. Controls n=76 oocytes from 4 batches, Co3O4 NPs 5 
min n=25 oocytes from 2 batches, Co3O4 NPs 20 min n=30 oocytes from 2 
batches, Aggregated Co3O4 NPs n=44 oocytes from 2 batches, Co NPs n=30 
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oocytes from 2 batches – statistical analysis performed with a One-Way 
ANOVA test with a Bonferroni-Holm post-hoc test. 
Cobalt-based NP effects on oocyte membrane biophysical 
parameters 
We have measured the effects of cobalt (Co) and cobalt oxide (Co3O4) 
NPs on the membrane biophysical parameters of Xenopus laevis oocytes 
(Figure 1) by determining membrane capacitance, resting potential, 
membrane resistance, membrane current reported as current-voltage 
(I/V) relationships as explained in Materials and Methods. Before 
exposing oocytes to cobalt and cobalt oxide NPs, we carefully sonicated 
NPs to disperse them as much as possible. We considered two time 
ranges in which we performed the measurements: a) within 5 min and 
b) after 20 min from the beginning of the exposure that occurs just after 
sonication. These two time ranges were selected after preliminary 
experiments conducted testing the oocytes every two min over 30 min 
(data not shown). These exposure time ranges agree with those 
previously observed for iron oxide NPs (Zanella et al., 2017). 
We first measured the biophysical membrane parameters of oocytes 
exposed to cobalt oxide NPs within 5 min from the beginning of the 
exposure and we recorded a significant reduction of resting potential 
and of membrane resistance. The resting potential decreased by about 5 
mV (Figure 1B), a reduction that can be explained by a small flux of ions 
permeating the plasma membrane. Also, after 5 min exposure to cobalt 
oxide NPs, membrane resistance was significantly lower than that of the 
control oocytes (Figure 1C) and its decrease was consistent with the 
decrease of resting potential described above. These parameter changes 
are well described by the I/V curves (Figure 1D). Indeed, we recorded a 
marked and statistically significant increase in the slope of the I/V 
relationship for a broad range of potentials (-120 to +50 mV), which 
corresponds to an increase of membrane conductance. Moreover, it is 
~ 121 ~ 
 
worth noting that the reversal potential of the I/V curve of the 5 min 
treatment remained the same of the control one, suggesting the presence 
of a non-selective conductance. 
We then measured the same parameters in oocytes that were exposed 
to cobalt oxide NPs for more than 20 min. We noticed that they did not 
differ from controls (Figure 1 A, B, C) and the I/V curve overlapped with 
the control one, demonstrating the transient nature of the non-selective 
conductance. 
Since we had previously hypothesized that aggregation was a key factor 
in membrane permeation, we have also tested aggregated cobalt oxide 
NPs. After sonication, NPs were left to aggregate for 30 min. Oocytes 
were exposed to the aggregated material and were tested with the same 
timing previously used, i.e. within 5 min and after 20 min from the NP 
addition. Here we did not observe any modification of the membrane 
parameters collected within 5 min (Figure 1) and after 20 min (data not 
shown). The absence of any effect of the aggregated Co3O4 NPs on 
membrane parameters was also seen with fluorescence experiments, in 
which intracellular calcein was not quenched (data not shown). 
We have exposed oocytes also to zerovalent cobalt NPs. As for cobalt 
oxide NPs, zerovalent ones were sonicated just before exposure. Here 
again, we measured the membrane biophysical parameters within 5 min 
from sonication and after 20 min. As shown in Figure 1, zerovalent 
cobalt NPs did not modify membrane biophysical parameters. No 
statistically significant changes versus control oocytes were recorded 
for membrane resistance (Figure 1C), indicating no changes in the 
integrity of the plasma membrane. Similarly, the I/V curve of the 
oocytes exposed to zerovalent cobalt NPs did not differ from the control 
one (Figure 1D). We obtained similar results also for oocytes exposed 
for more than 20 min (data not shown). Additionally, we have measured 
membrane capacitance for all the tested conditions without finding any 
modification. Since capacitance is related to the nature and the 
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extension of the membrane, we think that none of the treatments caused 
drastic changes in membrane surface area, such as endocytosis or 
exocytosis. 
Characterization of cobalt-based NPs 
Membrane biophysical parameters of oocytes exposed to the various 
cobalt-based NPs changed according to the time in which the 
measurement occurred and to the NP type (Figure 1). Therefore, we 
have performed the characterization of cobalt and cobalt oxide NPs, to 
correlate the physico-chemical properties of the NPs with their 
biological outcome (Figure 2). 
Both cobalt-based NPs were not stable in suspension. Indeed, in the 
experimental medium both NPs have a neutral z-potential (0.40 ± 0.06 
mV for Co NPs, Figure 2A, and 0.52 ± 0.09 mV for Co3O4 NPs, Figure 
2B). We have followed their aggregation dynamics by SLS (Figure 2C 
and D) in the time range that we used for measuring membrane 
biophysical parameters. The aggregation rate diverged between Co 
NPs, which in the experimental medium were not dispersed as sub-
micron particles, and Co3O4 NPs, which after sonication presented a 
small fraction of transiently dispersed NPs. However, after 5 min, this 
fraction was no longer detectable due to aggregation. 
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Figure 2: Co-based NPs characterization. Charge and hydrodynamic size 
of zerovalent Cobalt NPs (Co NPs) in A and C and Cobalt Oxide NPs (Co3O4 
NPs) in B and D, 0.1 mg/mL in buffered solution. Zeta potentials (A-B) were 
determined by Laser Doppler Micro-electrophoresis as 0.40 ± 0.06 mV for 
zerovalent Cobalt NPs and 0.52 ± 0.09 mV for Cobalt Oxide NPs (n=3). 
Hydrodynamic sizes were determined over time by Static Light Scattering and 
reported in C for Co NPs and in D for Co3O4 NPs; the insets represent an 
enlargement of the main graph, to highlight the NP population in the 0.01 to 1 
M range (representative experiments). 
Importance of protein corona on membrane biophysical parameters 
We have treated cobalt oxide NPs with bovine serum albumin (BSA), 
since it interacts with the NP surface to form a protein corona. We have 
seen that whilst the superficial charge of NPs was not significantly 
modified by the presence of protein corona, their hydrodynamic size 
was markedly reduced (Figure 3). Indeed, the submicron population 
was still present after 20 min, in contrast with that for bare Co3O4 NPs 
that disappeared after 5 min (Figure 2). 
Furthermore, as shown in Figure 3, BSA-coated NPs caused no 
significant change of the considered membrane biophysical parameters. 

















































































































Figure 3: Co3O4 NPs+BSA characterization and effects on plasma 
membrane. A-B) Charge and hydrodynamic size of Cobalt Oxide NPs (Co3O4 
NPs), 0.1 mg/mL in buffered solution + 1 mg/mL BSA. Zeta potential (A) was 
determined by Laser Doppler Micro-electrophoresis as -0.35 ± 0.11 mV (n=3). 
Hydrodynamic size (B) was determined over time by Static Light Scattering 
(representative experiment). C-F) Membrane capacitance, resting potential, 
membrane resistance and membrane current at=-120mV of oocytes treated as 
indicated in Materials and Methods. Controls n=26 oocytes from 2 batches, 
Co3O4 NPs, 5 min, n=13 oocytes from 2 batches, Controls + BSA, n=29 oocytes 
from 2 batches, Co3O4 NPs + BSA, 5 min, n=29 oocytes from 2 batches. 
Statistical analysis performed with a One-Way ANOVA test with a 
Bonferroni-Holm post-hoc test.  
Nickel-based NPs do not cross membrane and modify its 
biophysical parameters  
To complete the picture on transition metal-based NPs, we have 
performed fluorescence and electrophysiological analysis to investigate 
if also nickel-based NPs could cross directly the membrane. To this aim, 
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we tested if oxide and zerovalent nickel NPs were able to increase the 
cytosolic nickel content and to modify the resting potential, membrane 
resistance and membrane currents. 
The diffusion of metal NPs through the plasma membrane into the cell 
would cause a cytoplasmic rise of dissolved metal ions, which could be 
detected by calcein quenching (Bossi et al., 2016, Zanella et al., 2017). To 
determine whether nickel-based NPs were able to cross the plasma 
membrane of Xenopus oocyte and diffuse into the cytoplasm, we first 
evaluated NP dissolution in the experimental buffer by measuring the 
amount of released nickel ions generating transport currents in oocytes 
expressing heterologous rDMT1 (Bossi et al., 2016). These experiments 
confirmed that nickel-based NPs release nickel ions. We also calculated 
calcein affinity for Ni2+ that resulted suitable for detecting cytoplasmic 
concentration after NP exposure (7.1 ± 1.5 µM; Data not shown). 
Then, we performed injection experiments as previously reported 
(Zanella et al., 2017), to evaluate the fluorophore performance in the 
intracellular environment in presence of increasing nickel 
concentrations. As shown in Figure 4 A, the injection of NiCl2 50 µM 
was able to completely quench calcein fluorescence (K0.5 determined 
with Logistic Fitting resulted 15.5 ± 5.9 µM), obtaining results 
comparable to those obtained for other metals tested in the intracellular 
environment. These data demonstrate that calcein is certainly able to 
detect Ni2+ ions in cytoplasm.  
The fluorescence approach was then used to investigate the effect of 
treatment with NiO NPs or Ni NPs on intracellular presence of nickel 
ions. The results of these experiments showed that none of the NPs 
tested nor the ionic solution of NiCl2 were able to quench calcein 
fluorescence (Figure 4B), suggesting that nickel NPs are not able to cross 
the cell membranes and confirming the absence of endogenous 
transporters for divalent cations.  
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Figure 4: Effects of nickel-based NPs tested by fluorescence. A) Residual 
fluorescence in presence of the indicated intracellular concentration of NiCl2; 
the red line represents the logistic fit of the data collected from n=64 to 67 
oocytes for each condition from 3 different batches. B) Normalized mean values 
of residual fluorescence of calcein after 30 min exposure to buffered solution, 
NiCl2 100µM, NiO NPs 0.1 mg/mL and Ni NPs 0.1 mg/mL. Controls n=11 
oocytes from 5 batches, NiCl2 100µM n=6 oocytes from 2 batches, NiO NPs 
n=23 oocytes from 3 batches, Ni NPs n=10 oocytes from 2 batches – Statistical 
analysis performed with a One-Way ANOVA test with a Bonferroni-Holm 
post-hoc test. 
As shown in Figure 5, NiO NPs did not modify resting potential, 
membrane resistance and I/V relationship of the oocytes neither when 
parameters were tested within 5 min from the beginning of the 
treatment nor after 20 min. Similarly, we did not detect any 
electrophysiological changes also when oocytes were exposed to 
zerovalent nickel NPs. 
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Figure 5: Effects of nickel-based NPs on plasma membrane. Membrane 
capacitance, resting potential, membrane resistance and membrane current at 
Vm=-120 mV recorded from oocytes exposed to NiO NPs (A) and from oocytes 
exposed to Ni NPs (B).  Controls n=53 oocytes, NiO NPs 5 min n=34 oocytes, 
NiO NPs 20 min n=47 oocytes from 2 batches; Controls n=25 oocytes, Ni NPs 
5 min n=13 oocytes, Ni NPs 20 min n=23 from 2 batches - Statistical analysis 
performed with a One-Way ANOVA test with a Bonferroni-Holm post-hoc 
test. 
Characterization of nickel-based NPs 
Nickel NPs exhibited absence of net superficial charge (Figure 6A, z-
potential value of −0.17 ± 0.09 mV) and marked propensity to aggregate 
similarly to Co NPs. The presence of a submicron population can be 
recorded only immediately after NP addition to the experimental 
buffer, after which NPs immediately precipitated (as determined in 5 
independent experiments, Figure 6C). 
Conversely, NiO NPs exhibited a different behaviour from the 
previously studied metal oxide NPs, since the submicron population 
was always present in the 20 min of the hydrodynamic size 
experiments. Even with a neutral z-potential (Figure 6B, 0.045 ± 0.018 
mV), those particles could stay in the experimental medium 
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“threshold” identified to explain the different biological behaviour of 
oxide compared to elemental NPs (Figure 6D). However, the 
comparison of the dimensional distributions for cobalt and nickel oxide 
particles highlighted a difference in the dimension of the submicron 
population, since Co3O4 NPs were able to retain for 5 min a population 
below 200 nm, dimension that NiO NPs never had (Figure 7). 
 
 
Figure 6: Ni- based NPs characterization. Charge and hydrodynamic size 
of zerovalent Nickel NPs (Ni NPs - A and C) and Nickel Oxide NPs (NiO NPs 
– B and D), 0.1 mg/mL in buffered solution. Zeta potentials (A-B) were 
determined by Laser Doppler Micro-electrophoresis as −0.17 ± 0.09 mV for 
zerovalent Nickel NPs and 0.045 ± 0.018 mV for Nickel Oxide NPs (n=3). 
Hydrodynamic sizes (C-D) were determined over time by Static Light 
Scattering; the inset represents an enlargement of the main graph, to highlight 
the NP population among 0.01 to 1 M (bottom graphs, representative 
experiments). 
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Discussion 
Endocytosis is the canonical route whereby NPs are internalized by cells 
(Papis et al., 2009). However, an alternative mechanism has recently 
been suggested whereby NPs can directly cross the plasma membrane 
(Verma et al., 2008, Taylor et al., 2010, Lin and Alexander-Katz, 2013, 
Nolte et al., 2015, Zhang et al., 2015), thus bypassing the endosomal 
compartment. To investigate further this mechanism of NP uptake, we 
have made use of Xenopus laevis oocytes, which are large cells of 
approximately 1 mm in diameter, that for their characteristics, have 
become a convenient model for a variety of mechanistic studies (Bossi 
et al., 2007, Cens and Charnet, 2007, Zhang and Mandato, 2007, 
Bernareggi et al., 2015, Plautz et al., 2016). 
Using this model, we have been able to demonstrate that cobalt oxide 
NPs, but not zerovalent ones, caused an increase in cytoplasmic cobalt 
ion concentration (Bossi et al., 2016). We explained these results 
hypothesizing that NPs, after having crossed plasma membrane, 
dissolved inside the cytoplasm, causing an increase in Co2+ 
concentration that could be detected by the quenching of the fluorescent 
dye that we had previously injected into the oocytes. 
If this was the case, using an electrophysiological approach that 
monitors the integrity of the membrane, we should detect a conductance 
associated to the passage of the NPs. Indeed, we had measured a 
decrease in membrane resistance associated to the passage of iron oxide 
NPs (Zanella et al., 2017). In the present paper, we have reinvestigated 
cobalt-based NPs to understand if their passage through the membrane 
would also cause a transient decrease of the membrane resistance. As 
shown in Figure 1, after exposure to cobalt oxide NPs there is a 
significant decrease in resting potential and membrane resistance. These 
results can be explained by a leakage occurring when the NPs cross the 
plasma membrane, causing a non-selective flux of ions. Similarly to that 
observed with iron oxide NPs, this conductance is present in the first 5 
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min after the beginning of the exposure and disappears completely after 
20 min. 
The resistance recovery could be explained either by an aroused 
unresponsiveness of the oocyte membrane to NPs or by a change in NP 
capability to interact with and cross the membrane. Recent experiments 
with iron-based NPs made us to favour the latter hypothesis. Indeed, 
we had demonstrated that agglomeration impeded NP diffusion 
through the membrane (Zanella et al., 2017). To validate this hypothesis 
also for cobalt-based NPs, we have characterized their aggregation 
dynamics (Figure 2). The neutral z-potentials indicate that both NPs are 
unstable in our experimental medium, and SLS shows their tendency to 
aggregate over time. However, cobalt oxide NPs show a small (in terms 
of peak size of the volume-based measurement) submicron population 
of particles that could be those capable of diffusing through the 
membrane. Indeed, after 20 min this population disappears as well as 
the conductance in oocyte membrane. Conversely, zerovalent cobalt 
NPs do not present this population of dispersed NPs and are not able to 
cross the oocyte membrane. Hence, we have shown that the recovery of 
the oocyte membrane initial parameters that occurs after 20 min from 
the beginning of incubation is consistent with cobalt oxide NPs 
aggregating and no longer being able to cross the oocyte membrane. 
The results of the experiments with nickel-based NPs are also consistent 
with this hypothesis. Here in addition to the two-electrode voltage 
method we also have investigated particle internalisation using a 
fluorescence approach. These NPs (both zerovalent and oxide) did not 
have any effect on the biophysical membrane parameters (Figure 5), as 
well as on the cytosolic Ni2+ concentration (Figure 4), showing that they 
cannot cross the plasma membrane. Their z-potentials are neutral, and 
their populations are polydisperse as for cobalt-based NPs (Figure 6). 
Ni NPs show a submicron population that precipitates too rapidly to 
have an impact on cell membranes. NiO NPs on the other hand show a 
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submicron population stable for the whole experiment length; the lack 
of effects could be due to the fact that, as shown in Figure 7, the 
submicron population hydrodynamic size is larger than that of cobalt 
oxide, indicating the presence bigger particles that are evidently not 
capable of diffusing through the membrane. 
Taking all these considerations together, we propose that NPs, to diffuse 
though the membrane, should not be aggregated. However, dispersion 
is a necessary, but not sufficient, condition to allow NP membrane 
crossing. Our experiments with BSA-coated cobalt oxide NPs clearly 
show that those NPs were not able to modify oocyte membrane 
biophysical parameters, as bare cobalt oxide NPs did. We determined 
by SLS that the BSA-coated cobalt oxide NPs retain a dispersed 
population below 200 nm during the whole experiment, in sharp 
contrast with that of bare cobalt oxide NPs that start aggregating after 5 
min. Notwithstanding BSA-coated NPs remaining dispersed, they do 
not enter inside the cells possibly because of the protein corona, which 
prevents particle-particle interactions as well as membrane-particle 
interactions. 
NP coating is thus another a key factor to consider when studying the 
interactions of NPs with the plasma membrane. However, other factors 
could influence the process of NP diffusion through the membrane such 
as the crystalline structures of the NPs, which are different between the 
two metal oxide NPs (normal spinel for Co3O4, octahedral for NiO). 
The detailed study of the interactions of NPs with membranes can be 
useful for designing engineered NPs as well as for a better 
comprehension of nanotoxicology. We could exploit this information to 
deliver engineered NPs functionalized with drugs, enzymes (Balzaretti 
et al., 2017), DNA and antibiotics (Conde et al., 2014, Armenia et al., 2018) 
to the appropriate cell compartments through different cell access 
routes. Moreover, the possibility that NPs can transiently modify the 
membrane resting potential need to be considered while evaluating 
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their cytotoxicity or therapeutic potential. Indeed, alteration in 
membrane potential can act on different intracellular pathways. 
 
 
Figure 7: Hydrodynamic size distributions of Co3O4 and NiO NPs. 
Comparison of the distributions of Co3O4 (continuous lines) and NiO NPs 
(non-continuous lines) within 5 min from the start of the measurements in the 
experimental medium. Submicron dimensional range in the inset, red square 
for the 200 nm threshold. Representative experiment. 
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Materials and Methods 
Solutions 
Buffered solution (ND96) had the following composition (in mM): NaCl 
96, KCl 2, CaCl2 1.8, MgCl2 1, HEPES 5, pH 7.6; NDE solution was 
composed of ND96 plus 2.5 mM pyruvate and 50 µg/mL Gentamycin 
sulphate; intracellular solution contained (in mM): KCl 130, NaCl 4, 
MgCl2 1.6, EGTA 5, HEPES 10, glucose 5, pH 7.6. The final pH values of 
5.5 or 7.6 were adjusted with HCl and NaOH. 
Oocytes collection and preparation 
Oocytes were obtained from adult Xenopus laevis females. Animals were 
anaesthetised in 0.1 % (w/v) MS222 (tricaine methansulfonate) solution 
in tap water; after carefully cleaning the frog abdomen with an 
antiseptic agent (Povidone-iodine 10%), laparotomy was performed 
and portions of the ovary were collected. The oocytes were treated with 
0.5 mg/mL collagenase (Sigma Type IA) in ND96 calcium free for at least 
30 min at 18 °C. Healthy and fully grown oocytes were selected and 
stored at 18°C in NDE solution. The oocytes to be transfected with the 
cRNA coding for rDMT1 were injected with 25 ng of cRNA in 50 nL of 
water, the day after the removal, using a manual microinjection system 
(Drummond Scientific Company, Broomall, PA) and incubated at 18 °C 
for 3-4 days before electrophysiological or fluorescence experiments. 
The experimental protocol was approved locally by the Committee of 
the “Organismo Preposto al Benessere degli Animali” of the University 
of Insubria (OPBA-permit #02_15) and nationally by Ministero della 
Salute (permit nr. 1011/2015). 
NP preparation and incubation conditions 
The cobalt-based NPs used were Zerovalent (Co, 25 nm, IOLITEC, 
Salzstrasse 184, D-74076 Heilbronn) and oxide (Co3O4, < 50 nm TEM 
determined, Sigma-Aldrich). The nickel-based NPs used were 
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zerovalent (Ni, 25 nm, IOLITEC, Salzstrasse 184, D-74076 Heilbronn) 
and oxide (NiO, < 50 nm TEM determined, Sigma-Aldrich). All NPs 
were prepared as 10 mg/mL stock suspensions in deionised water and 
sonicated before the addition of 10 µL to the test chamber (4 wells plate) 
containing 990 µL of buffered solution (pH 7.6) where oocytes were then 
added. The conditions applied for oocytes NPs exposure were: 
Controls, oocytes exposed only to buffered solution, oocytes exposed to 
Co3O4 NPs and tested within 5 minutes from the NPs sonication, oocytes 
exposed to Co3O4 NPs and tested after 20 minutes from the NPs 
sonication, oocytes exposed to Co3O4 NPs that were let to aggregate for 
30 minutes before adding them to the incubation chamber, and finally 
oocytes exposed to zerovalent Co NPs.  
For electrophysiological experiments, the oocytes were transferred to 
the TEVC recording chamber within 5 min or after 20 min from the 
beginning of the exposure. For the fluorescence assay, recordings start 
immediately after oocytes addition to the test chamber. Treatments with 
the aggregated NPs were performed adding oocytes to the suspension 
of NPs that were let to aggregate in the test chamber for 30 min after 
sonication. Experiments with BSA were carried out using buffered 
containing 1 mg/mL BSA, in which were added NPs and oocytes. 
All experiments were carried out at room temperature. 
Fluorescence Assay 
Oocytes were injected with a 50 nL drop of intracellular solution 
containing 25 µM calcein. In dose-response evaluation experiments, 
solutions containing calcein and increasing amounts of NiCl2 were co-
injected in oocytes. Effective intracellular metal concentrations were 
calculated using the nominal oocyte volume of 1 µL. Images were 
acquired for every oocyte at fixed acquisition parameters, calculated on 
control oocytes (oocytes injected only with calcein). 
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In experiments with NPs, images of single oocytes in each experimental 
condition applied were acquired every 2 min for 30 min with a 
fluorescence microscope (AxioVert 200, Carl Zeiss with a 4x objective, 
COLIBRI fluorescence filters, 470 nm excitation - 515 to 565 nm 
emission) equipped with CCD camera (True Chrome HD II S T 
EsseLab). 
Electrophysiology 
The two-electrode voltage clamp was performed with an Oocyte Clamp 
OC-725B (Warner Instruments, Hamden, CT, USA) that was controlled 
by Clampex 10.2 (Molecular Devices, Sunnyvale, CA, USA, 
www.moleculardevices.com). Intracellular glass microelectrodes, filled 
with 3 M KCl, had tip resistances in the 0.5 - 4 MΩ range. Agar bridges 
(3% agar in 3 M KCl) connected the bath electrodes to the experimental 
chamber. The holding potential (Vh) was -40 mV for all the experiments 
performed. The capacitance and resistance values reported were 
obtained applying 10 mV steps of 20 ms every 200 ms in voltage clamp 
conditions. The voltage pulses protocol, after 200 ms at the holding 
potential applied 10 mV voltage steps from -120 to +50 mV for 750 ms, 
and return to the holding potential for other 400 ms, the interval 
between stimuli was of 1 s. 
Oocytes were transferred in the recording chamber (Warner-RC-1Z, 
warneronline.com) and impaled with microelectrodes; to recover from 
possible damage they were left for 2 min in a continuous solution flux. 
Only oocytes with resting potential equal or lower than -20 mV were 
used for the experiments. The number of discarded oocytes was not 
significantly different between treated and controls. 
Data analysis 
Data were analysed using Clampfit 10.2 software (Molecular Devices, 
Sunnyvale, CA, USA, www.moleculardevices.com) while OriginPro 8.0 
(OriginLab Corp., Northampton, MA, USA, www.originlab.com) was 
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used for statistics and figure preparation. For the Voltage Step protocol, 
current values were measured for every voltage step at the steady state 
condition; mean values at every voltage were calculated and plotted. 
Fluorescence decay images were analysed with ImageJ (Rasband, W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2015). For F30/F0 quantification, the 
fluorescence intensity at time 0 (F0) and at time 30 min (Ft) was 
calculated in the entire area of the oocyte. In dose-response experiments, 
images were analysed calculating fluorescence intensity on the entire 
area of oocytes and normalized to the control oocytes. Mean values were 
calculated for every condition and used to determine through a non-
linear fitting (Logistic Fitting, OriginPro8) the K0.5, relating residual 
fluorescence to metal concentration. 
Static light scattering (SLS) 
SLS was performed on a Mastersizer 2000 with a Hydro 2000µP Micro 
Precision sample dispersion unit (Malvern Instruments Limited). 
Baseline correction was carried out with fresh buffered solution. Next, 
200 µL of 10 mg/mL stock suspension was added to the 20 mL 
dispersion cell to achieve a final concentration of 0.1 mg/mL (as per 
Oocyte assays). The dispersion unit was run at 1000 rpm and care was 
taken to prevent bubble formation. The stock suspension was carefully 
sonicated prior to introduction to the dispersion cell, after which data 
acquisition was immediately initiated. Size measurements then were 
carried out over a period of 30 min (absorption 1.0; dispersant refractive 
index: 1.33; particles refractive index: Co3O4: 1.74 – Co: 2.14 – NiO: 2.18 
– Ni: 1.98). 
Zeta potential 
The zeta potential of suspensions of iron NPs was determined by Laser 
Doppler Micro-electrophoresis (Zetasizer NanoZS, Malvern 
Instruments Ltd) using disposable folded capillary cells (DTS1070). 
~ 137 ~ 
 
Measurements (n=3) were carried out using the diffusion barrier as per 
instrument manufacturer instructions. Briefly, the zeta cell was filled 
with 1 mM NaCl solution and then 100 µL sample (0.1 mg/mL 
suspension of NPs in buffered solution) was gently injected to the 
bottom of the cell with a gel-loading tip. Electrophoretic mobility of 
particles was converted into zeta potentials by Dispersion Technology 
Software 7.11 using the Smoluchowski approximation, and a viscosity 
of 0.8872cP and dielectric constant of 78.5 for the dispersant. Results are 
expressed as mean ± standard deviation. 
Bibliography 
Ahamed, M., Ali, D., Alhadlaq, H.A. & Akhtar, M.J., 2013. Nickel oxide 
nanoparticles exert cytotoxicity via oxidative stress and induce 
apoptotic response in human liver cells (HepG2). Chemosphere, 
93, 2514-22. 
Alkhammash, H.I., Li, N., Berthier, R. & De Planque, M.R., 2015. Native 
silica nanoparticles are powerful membrane disruptors. Phys 
Chem Chem Phys, 17, 15547-60. 
Amde, M., Liu, J.F., Tan, Z.Q. & Bekana, D., 2017. Transformation and 
bioavailability of metal oxide nanoparticles in aquatic and 
terrestrial environments. A review. Environmental Pollution, 230, 
250-267. 
Anders, C.B., Eixenberger, J.E., Franco, N.A., Hermann, R.J., Rainey, 
K.D., Chess, J.J., Punnoose, A. & Wingett, D.G., 2018. ZnO 
nanoparticle preparation route influences surface reactivity, 
dissolution and cytotoxicity. Environ Sci Nano, 5, 572-588. 
Ansari, S.M., Bhor, R.D., Pai, K.R., Sen, D., Mazumder, S., Ghosh, K., 
Kolekar, Y.D. & Ramana, C.V., 2017. Cobalt nanoparticles for 
biomedical applications: Facile synthesis, physiochemical 
characterization, cytotoxicity behavior and biocompatibility. 
Applied Surface Science, 414, 171-187. 
Armenia, I., Marcone, G.L., Berini, F., Orlandi, V.T., Pirrone, C., 
Martegani, E., Gornati, R., Bernardini, G. & Marinelli, F., 2018. 
Magnetic nanoconjugated teicoplanin: a novel tool for bacterial 
infection site targeting. Frontiers in Microbiology 9. 
~ 138 ~ 
 
Arvizo, R.R., Miranda, O.R., Thompson, M.A., Pabelick, C.M., 
Bhattacharya, R., Robertson, J.D., Rotello, V.M., Prakash, Y.S. & 
Mukherjee, P., 2010. Effect of nanoparticle surface charge at the 
plasma membrane and beyond. Nano Lett, 10, 2543-8. 
Balzaretti, R., Meder, F., Monopoli, M.P., Boselli, L., Armenia, I., 
Pollegioni, L., Bernardini, G. & Gornati, R., 2017. Synthesis, 
characterization and programmable toxicity of iron oxide 
nanoparticles conjugated with D-amino acid oxidase. Rsc 
Advances, 7, 1439-1442. 
Bannunah, A.M., Vllasaliu, D., Lord, J. & Stolnik, S., 2014. Mechanisms 
of nanoparticle internalization and transport across an intestinal 
epithelial cell model: effect of size and surface charge. Molecular 
pharmaceutics, 11, 4363-73. 
Beddoes, C.M., Case, C.P. & Briscoe, W.H., 2015. Understanding 
nanoparticle cellular entry: A physicochemical perspective. 
Advances in colloid and interface science, 218, 48-68. 
Bernareggi, A., Ren, E., Borelli, V., Vita, F., Constanti, A. & Zabucchi, G., 
2015. Xenopus laevis Oocytes as a Model System for Studying 
the Interaction Between Asbestos Fibres and Cell Membranes. 
Toxicol Sci, 145, 263-72. 
Bhuvaneshwari, M., Kumar, D., Roy, R., Chakraborty, S., Parashar, A., 
Mukherjee, A., Chandrasekaran, N. & Mukherjee, A., 2017. 
Toxicity, accumulation, and trophic transfer of chemically and 
biologically synthesized nano zero valent iron in a two species 
freshwater food chain. Aquatic Toxicology, 183, 63-75. 
Bossi, E., Fabbrini, M.S. & Ceriotti, A., 2007. Exogenous protein 
expression in Xenopus Laevis Oocyte, Basic procedure. In G. 
Grandi (ed.) In Vitro Transcription and translation Protocols. 375 
ed. Totowa NJ: Humana Press, 107-131. 
Bossi, E., Zanella, D., Gornati, R. & Bernardini, G., 2016. Cobalt oxide 
nanoparticles can enter inside the cells by crossing plasma 
membranes. Sci Rep, 6, 22254. 
Brandenberger, C., Muhlfeld, C., Ali, Z., Lenz, A.-G., Schmid, O., Parak, 
W.J., Gehr, P. & Rothen-Rutishauser, B., 2010. Quantitative 
evaluation of cellular uptake and trafficking of plain and 
polyethylene glycol-coated gold nanoparticles. Small (Weinheim 
an der Bergstrasse, Germany), 6, 1669-78. 
~ 139 ~ 
 
Cens, T. & Charnet, P., 2007. Use of Xenopus oocytes to measure ionic 
selectivity of pore-forming peptides and ion channels. Methods 
Mol Biol, 403, 287-302. 
Chen, J., Hessler, J.A., Putchakayala, K., Panama, B.K., Khan, D.P., 
Hong, S., Mullen, D.G., Dimaggio, S.C., Som, A., Tew, G.N., 
Lopatin, A.N., Baker, J.R., Holl, M.M. & Orr, B.G., 2009. Cationic 
nanoparticles induce nanoscale disruption in living cell plasma 
membranes. J Phys Chem B, 113, 11179-85. 
Cho, E.C., Au, L., Zhang, Q. & Xia, Y., 2010. The effects of size, shape, 
and surface functional group of gold nanostructures on their 
adsorption and internalization by cells. Small, 6, 517-22. 
Conde, J., Dias, J.T., Grazu, V., Moros, M., Baptista, P.V. & De La Fuente, 
J.M., 2014. Revisiting 30 years of biofunctionalization and 
surface chemistry of inorganic nanoparticles for nanomedicine. 
Front Chem, 2, 48. 
Date, A.A., Hanes, J. & Ensign, L.M., 2016. Nanoparticles for oral 
delivery: Design, evaluation and state-of-the-art. J Control 
Release, 240, 504-526. 
Ding, H.-M. & Ma, Y.-Q., 2015. Theoretical and computational 
investigations of nanoparticle-biomembrane interactions in 
cellular delivery. Small (Weinheim an der Bergstrasse, Germany), 
11, 1055-71. 
Frohlich, E., 2012. The role of surface charge in cellular uptake and 
cytotoxicity of medical nanoparticles. International journal of 
nanomedicine, 7, 5577-91. 
Frohlich, E., 2013. Cellular targets and mechanisms in the cytotoxic 
action of non-biodegradable engineered nanoparticles. Curr 
Drug Metab, 14, 976-88. 
Horev-Azaria, L., Kirkpatrick, C.J., Korenstein, R., Marche, P.N., 
Maimon, O., Ponti, J., Romano, R., Rossi, F., Golla-Schindler, U., 
Sommer, D., Uboldi, C., Unger, R.E. & Villiers, C., 2011. 
Predictive toxicology of cobalt nanoparticles and ions: 
comparative in vitro study of different cellular models using 
methods of knowledge discovery from data. Toxicological sciences 
: an official journal of the Society of Toxicology, 122, 489-501. 
Horie, M., Fukui, H., Nishio, K., Endoh, S., Kato, H., Fujita, K., 
Miyauchi, A., Nakamura, A., Shichiri, M., Ishida, N., Kinugasa, 
~ 140 ~ 
 
S., Morimoto, Y., Niki, E., Yoshida, Y. & Iwahashi, H., 2011. 
Evaluation of Acute Oxidative Stress Induced by NiO 
Nanoparticles In Vivo and In Vitro. Journal of Occupational 
Health, 53, 64-74. 
Horie, M., Yoshiura, Y., Izumi, H., Oyabu, T., Tomonaga, T., Okada, T., 
Lee, B.W., Myojo, T., Kubo, M., Shimada, M. & Morimoto, Y., 
2016. Comparison of the Pulmonary Oxidative Stress Caused by 
Intratracheal Instillation and Inhalation of NiO Nanoparticles 
when Equivalent Amounts of NiO Are Retained in the Lung. 
Antioxidants, 5. 
Li, Y., Zhang, X. & Cao, D., 2015. Nanoparticle hardness controls the 
internalization pathway for drug delivery. Nanoscale, 7, 2758-69. 
Li, Z., Zhang, Y., Zhu, D., Li, S., Yu, X., Zhao, Y., Ouyang, X., Xie, Z. & 
Li, L., 2017. Transporting carriers for intracellular targeting 
delivery via non-endocytic uptake pathways. Drug Delivery, 24, 
45-55. 
Lin, J. & Alexander-Katz, A., 2013. Cell membranes open "doors" for 
cationic nanoparticles/biomolecules: insights into uptake 
kinetics. ACS Nano, 7, 10799-808. 
Moghadam, B.Y., Hou, W.C., Corredor, C., Westerhoff, P. & Posner, J.D., 
2012. Role of nanoparticle surface functionality in the disruption 
of model cell membranes. Langmuir, 28, 16318-26. 
Morimoto, Y., Hirohashi, M., Ogami, A., Oyabu, T., Myojo, T., Hashiba, 
M., Mizuguchi, Y., Kambara, T., Lee, B.W., Kuroda, E. & Tanaka, 
I., 2011. Pulmonary Toxicity Following an Intratracheal 
Instillation of Nickel Oxide Nanoparticle Agglomerates. Journal 
of Occupational Health, 53, 293-295. 
Nativo, P., Prior, I.A. & Brust, M., 2008. Uptake and intracellular fate of 
surface-modified gold nanoparticles. ACS Nano, 2, 1639-44. 
Nolte, T.M., Kettler, K., Meesters, J.A., Hendriks, A.J. & Van De Meent, 
D., 2015. A semi-empirical model for transport of inorganic 
nanoparticles across a lipid bilayer: implications for uptake by 
living cells. Environ Toxicol Chem, 34, 488-96. 
Ortega, R., Bresson, C., Darolles, C., Gautier, C., Roudeau, S., Perrin, L., 
Janin, M., Floriani, M., Aloin, V., Carmona, A. & Malard, V., 
2014. Low-solubility particles and a Trojan-horse type 
~ 141 ~ 
 
mechanism of toxicity: the case of cobalt oxide on human lung 
cells. Particle and fibre toxicology, 11, 14. 
Papis, E., Rossi, F., Raspanti, M., Dalle-Donne, I., Colombo, G., Milzani, 
A., Bernardini, G. & Gornati, R., 2009. Engineered cobalt oxide 
nanoparticles readily enter cells. Toxicology Letters, 189, 253-259. 
Peetla, C. & Labhasetwar, V., 2009. Effect of molecular structure of 
cationic surfactants on biophysical interactions of surfactant-
modified nanoparticles with a model membrane and cellular 
uptake. Langmuir, 25, 2369-77. 
Peters, A., Veronesi, B., Calderon-Garciduenas, L., Gehr, P., Chen, L.C., 
Geiser, M., Reed, W., Rothen-Rutishauser, B., Schurch, S. & 
Schulz, H., 2006. Translocation and potential neurological effects 
of fine and ultrafine particles a critical update. Particle and fibre 
toxicology, 3, 13. 
Plautz, C.Z., Williams, H.C. & Grainger, R.M., 2016. Functional Cloning 
Using a Xenopus Oocyte Expression System. J Vis Exp, e53518. 
Sabbioni, E., Fortaner, S., Farina, M., Del Torchio, R., Olivato, I., 
Petrarca, C., Bernardini, G., Mariani-Costantini, R., Perconti, S., 
Di Giampaolo, L., Gornati, R. & Di Gioacchino, M., 2014a. 
Cytotoxicity and morphological transforming potential of cobalt 
nanoparticles, microparticles and ions in Balb/3T3 mouse 
fibroblasts: an in vitro model. Nanotoxicology, 8, 455-64. 
Sabbioni, E., Fortaner, S., Farina, M., Del Torchio, R., Petrarca, C., 
Bernardini, G., Mariani-Costantini, R., Perconti, S., Di 
Giampaolo, L., Gornati, R. & Di Gioacchino, M., 2014b. 
Interaction with culture medium components, cellular uptake 
and intracellular distribution of cobalt nanoparticles, 
microparticles and ions in Balb/3T3 mouse fibroblasts. 
Nanotoxicology, 8, 88-99. 
Shimizu, K., Nakamura, H. & Watano, S., 2016. MD simulation study of 
direct permeation of a nanoparticle across the cell membrane 
under an external electric field. Nanoscale, 8, 11897-906. 
Shin, E.H., Li, Y., Kumar, U., Sureka, H.V., Zhang, X. & Payne, C.K., 
2013. Membrane potential mediates the cellular binding of 
nanoparticles. Nanoscale, 5, 5879-86. 
~ 142 ~ 
 
Song, B., Yuan, H., Pham, S.V., Jameson, C.J. & Murad, S., 2012. 
Nanoparticle permeation induces water penetration, ion 
transport, and lipid flip-flop. Langmuir, 28, 16989-7000. 
Taylor, U., Klein, S., Petersen, S., Kues, W., Barcikowski, S. & Rath, D., 
2010. Nonendosomal Cellular Uptake of Ligand-Free, Positively 
Charged Gold Nanoparticles. Cytometry Part A, 77a, 439-446. 
Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.S., Watson, N., Chen, S., 
Irvine, D.J. & Stellacci, F., 2008. Surface-structure-regulated cell-
membrane penetration by monolayer-protected nanoparticles. 
Nat Mater, 7, 588-95. 
Warren, E.A. & Payne, C.K., 2015. Cellular binding of nanoparticles 
disrupts the membrane potential. RSC Adv, 5, 13660-13666. 
Zanella, D., Bossi, E., Gornati, R., Bastos, C., Faria, N. & Bernardini, G., 
2017. Iron oxide nanoparticles can cross plasma membranes. 
Scientific reports, 7, 11413. 
Zhang, H., Ji, Q., Huang, C., Zhang, S., Yuan, B., Yang, K. & Ma, Y.Q., 
2015. Cooperative transmembrane penetration of nanoparticles. 
Sci Rep, 5, 10525. 
Zhang, T. & Mandato, C.A., 2007. Xenopus oocyte wound healing as a 
model system for analysis of microtubule-actin interactions. 
Methods Mol.Med., 137, 181-188. 
 
  
~ 143 ~ 
 
Chapter 5 
Interactions of γ-Fe2O3 NPs and γ-Fe2O3 NPs functionalized 
with APTES with the membranes of the Xenopus laevis oocytes 
This Chapter contains unpublished data, regarding the research 
conducted on γ-Fe2O3 NPs uncoated and functionalized with APTES, 
starting from the particles synthesis to their physico-chemical 
characterization and biological testing. The research activity production 
is reported starting with a brief introduction on the particles and their 
importance, followed by a description of the techniques used and the 
methods applied and by the results of the experimental activities 
performed. 
Introduction 
Iron oxide NPs, and among them Superparamagnetic Iron Oxide NPs 
(SPIONs) are currently utilized in biomedical applications mainly due 
to their biocompatibility and the large possibility of customization[1-4]. 
SPIONs are suitable tools for numerous applications due to their 
inducible high magnetization when exposed to an externally applied 
magnetic field, that allows heating or targeting them to the area of 
interest, like a specific tissue[5-7]. Specific coatings are needed to stabilize 
NPs in suspension and to avoid their surface oxidation and 
consequently partial loss of their magnetic characteristics. The coating 
molecules often merely act as a barrier to protect the NPs against 
external agents, but sometimes happen to drastically affect the 
electronic properties of the NPs[8]. 
Concerning their biocompatibility, many studies report iron oxide NPs 
to be highly biocompatible and to have with very low toxicity[9-14],[23]. 
Some papers however show contradictory results[15-19], demanding more 
detailed analysis to assess in vitro (cellular effects, ROS generation, ions 
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release and genetic effects) and in vivo (toxicokinetics, acute toxicity, 
genotoxicity, neurotoxicity, immunotoxicity and reproductive toxicity) 
mechanisms and effects. Further studies will be helpful in filling the 
main knowledge gaps in the iron oxide NP safety and toxicity fields. 
The work reported here focuses on both aspects; understanding if 
uncoated SPIONs and coated ones can cross plasma membrane 
bypassing endocytosis would spread even more the range of possible 
use for these particles and would give also some clues about a 
mechanism of possible toxicity that has been often underestimated. The 
SPIONs tested in this work are maghemite (γ-Fe2O3, from here onward 
reported as Fe2O3 NPs) NPs, which are already used in many fields[5, 
20][24, 25] and maghemite NPs functionalized with 3-
aminopropyltriethoxylsilane (APTES), to achieve the surface 
stabilization and to make surface functionalization with biomolecules 
possible[26, 27]. 
Materials and Methods 
Oocytes Collection and Preparation 
See “Oocytes Collection and Preparation” section in Materials and 
Methods - Chapter 4. 
γ-Fe2O3 NPs Synthesis 
γ-Fe2O3 were synthetized following a protocol based on [26]. The 
synthesis was performed in an Erlenmeyer flask positioned on a heating 
plate with a magnetic stirrer. Because of the risk of production of nitrous 
gases in the heating steps, the synthesis was conducted under a working 
fume-hood. The synthesis yield will approximately be 50 mL of aqueous 
γ-Fe2O3 NPs dispersion. 
1. Add 8.89 g FeCl3 * 6 H2O (Sigma-Aldrich n. cat: 31232) and 3.28 
g FeCl2 * 4 H2O (Sigma-Aldrich n. cat: 44939) in 380 mL H2O (in 
a 500 mL Erlenmeyer flask) on a magnetic stirrer for 30 min. 
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While stirring add slowly 1.5 mL of 37% HCl to dissolve iron 
salts completely. 
2. Add slowly and under strong stirring 25 mL of 25% NH4OH to 
iron solution: a black precipitate will appear. Stir for additional 
10 min. 
3. Remove flask from magnetic stirrer and let particles precipitate 
by placing a permanent magnet (NdFeB-magnet) under the flask 
and wait until all the NPs are collected to the bottom (10-20 min). 
NdFeB-magnet magnetic field is very strong, so caution must be 
paid. 
4. Remove the supernatant (aqueous media) by decantation and 
wash twice the NPs with 100 mL of H2O MilliQ, leaving them 
10 min on magnetic stirrer for each washing. During the last 
washing steps, transfer the suspension into a smaller 
Erlenmeyer flask (100 mL). 
5. After the transfer, add 40 mL of 2 M HNO3 and heat up to 90 °C 
for a 5 min. The suspension will turn from black to dark brown. 
6. Isolate particles again with the magnet and add 60 mL of 0.34 M 
solution of Fe(NO3)3 * 9 H2O (Sigma-Aldrich n. cat: 216828). Heat 
up to 90 °C and stir for 30 min. 
7. Cool down to RT and remove supernatant (NdFeB-magnet). 
8. Add 50 mL of H2O (can be more) on the particles and stir 
properly. The particles will now “dissolve” leading to a 
magnetic fluid containing a well dispersion of iron oxide 
nanoparticles. 
9. Filter NPs through 0.2 µm syringe filters for removal of larger 
aggregates. If dispersion cannot be filtered well, add more water 
to dilute the ferrofluid and use new filter. 
10. Pipette into a glass bottle and store at 4 °C. If needed the iron 
oxide NPs solution can be dialyzed to remove any iron salts still 
present after the last steps. 
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γ-Fe2O3 NPs Functionalization with APTES 
γ-Fe2O3 were functionalized with APTES (Sigma n. cat: A3648). Since 
newly synthetized oxide NPs were suspended in aqueous media, the 
corresponding of 150 mg of NPs was added to 1 mL of a solution 
composed by 975.4 µL of EtOH and 24.6 µL of APTES. The right amount 
of APTES was calculated from the total NPs surface area to have enough 
APTES to coat each NP. EtOH was added up to the volume of 1 mL. The 
reaction was maintained under mechanical stirring for 1 h (RT) and for 
1 h (90 °C). Then, the synthetized γ-Fe2O3-APTES NPs were washed 
three times with H2O MilliQ by centrifugation 5 minutes at 10000 x g 
and resuspended in H2O MilliQ by ultrasonication. 
Amine group on the NPs-surface determination 
The amino content of the NPs was measured by the Orange II 
spectrophotometric assay[21, 22]: 1 mL of a solution of 1 mM Orange II pH 
3 was added to 1 mg of NPs and maintained under stirring for 30 min 
at 40°C. The particles were precipitated and washed with an acidic 
water solution until all the unbound dye was removed. To desorb the 
bound dye, a solution at pH 12 was added to the NPs. The amount of 
desorbed dye was then measured at a wavelength of 480 nm with a 
UV/vis spectrophotometer. 
NP Treatment Conditions 
All NPs were prepared as 10 mg/mL (particle weight) stock suspensions 
in deionised water and sonicated before the addition of 10 µL to the test 
chamber (4 wells plate) containing 990 µL of buffered solution (pH 7.6) 
where oocytes were then added.  
For electrophysiological experiments, the oocytes were transferred to 
the TEVC recording chamber within 5 min or after 20 min from the 
beginning of the exposure. For the fluorescence assay, recordings start 
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immediately after oocytes addition to the test chamber. All experiments 
were carried out at room temperature. 
Solutions 
See “Solutions” section in Materials and Methods - Chapter 4. 
FeCl3 (Sigma) was prepared fresh as a stock solution (50mM) in buffered 
solution and diluted to the working concentrations. 
Spectrofluorometry 
NP dissolution and release was evaluated by measuring calcein 
quenching (fixed concentration of 2.5 µM) in presence of increasing 
concentration of NPs, added to buffered solution pH 7.6 from the 10 
mg/mL stocks. Jasco FP-750 fluorometer with excitation at 470 nm, 
emission spectra measured in the 490 to 560 nm range. 
Fluorescence Assay 
See “Fluorescence Assay” section in Materials and Methods - Chapter 4. 
Electrophysiology 
The two-electrode voltage clamp was performed with an Oocyte Clamp 
OC-725B (Warner Instruments, Hamden, CT, USA) that was controlled 
by Clampex 10.2 (Molecular Devices, Sunnyvale, CA, USA, 
www.moleculardevices.com). Intracellular glass microelectrodes, filled 
with 3 M KCl, had tip resistances in the 0.5 - 4 MΩ range. Agar bridges 
(3% agar in 3 M KCl) connected the bath electrodes to the experimental 
chamber. The holding potential (Vh) was -40 mV for all the experiments 
performed. The capacitance and resistance values reported were 
obtained applying 10 mV steps of 20 ms every 200 ms in voltage clamp 
conditions. The voltage pulses protocol, after 200 ms at the holding 
potential applied 10 mV voltage steps from -120 to +50 mV for 750 ms, 
and return to the holding potential for other 400 ms, the interval 
between stimuli was of 1 s. 
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Oocytes were transferred in the recording chamber (Warner-RC-1Z, 
warneronline.com) and impaled with microelectrodes; to recover from 
possible damage they were left for 2 min in a continuous solution flux. 
Only oocytes with resting potential equal or lower than -20 mV were 
used for the experiments. The number of discarded oocytes was not 
significantly different between treated and controls.  
For Fe2O3 NPs, I/V relationships values were considered till +20 mV, 
after which there was the opening of endogenous conductances not 
related to the treatment (i.e. present also in the control condition) that 
forced us to exclude these data. 
Zeta Potential 
See “Zeta Potential” section in Materials and Methods - Chapter 4. 
Static Light Scattering (SLS) 
SLS was performed on a Mastersizer 2000 with a Hydro 2000µP Micro 
Precision sample dispersion unit (Malvern Instruments Limited). 
Baseline correction was carried out with fresh buffered solution. Next, 
200 µL of 10 mg/mL stock suspension was added to the 20 mL 
dispersion cell to achieve a final concentration of 0.1 mg/mL (as per 
Oocyte assays). The dispersion unit was run at 1000 rpm and care was 
taken to prevent bubble formation. The stock suspension was carefully 
sonicated prior to introduction to the dispersion cell, after which data 
acquisition was immediately initiated. Size measurements then were 
carried out over a period of 30 min (absorption 1.0; dispersant refractive 
index: 1.33; particles refractive index: 2.94). 
Data Analysis 
See “Data Analysis” section in Materials and Methods - Chapter 4. 
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Results and Discussion 
Fe3+ Uptake Evaluation 
As a first step, the presence of endogenous transporters for the metal 
ion deriving from the NPs (Fe3+) was evaluated. Increasing 
concentrations of FeCl3, 100 µM – 300 µM – 1 mM, were perfused on the 
oocytes clamped at -40mV, and membrane current was recorded. 
Results are reported in Figure 1. 
 
Figure 1: electrophysiological recording at -40 mV from control oocyte in 
buffered solution exposed to 100 µM, 300 µM and 1 mM FeCl3. Representative 
trace. 
As it is possible to see, a small conductance generating an inward ion 
flux opens at a concentration of 1 mM FeCl3. Although an endogenous 
metal transport it is present, the concentration that triggers the metal 
transport it is about tenfold of the estimated concentration of Fe3+ ions 
released at the working concentration of 0.1 mg/mL of Fe2O3 NPs, 
conditions used in our study (Figure 2).  
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Figure 2: electrophysiological recording at -40 mV from control oocyte in 
buffered solution exposed to 0.1 mg/mL Fe2O3 NPs. No currents were detected 
during exposition to NPs. Representative trace. 
The complete dissolution of the Fe2O3 NPs would be required to release 
1.25 mM Fe3+. The dissolution of any metal oxide is very hard to achieve, 
and it usually requires an acidic pH, rather than the neutral-slightly 
basic pH of the buffered solution used in this study (7.6). Total 
dissolution of the particles in the condition used is most unlikely. 
Therefore, the endogenous metal transporter presence do not affect the 
experimental data of this study. 
Fluorescence Evaluation 
The binding of the probe calcein with the ions released from the NPs 
was evaluated through spectrofluorometry. 
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Figure 3: emission spectra (means, n=3) obtained monitoring fixed calcein 
concentration with the addition of increasing concentrations of Fe2O3 NPs (left) 
and Fe2O3-APTES NPs (right). 
From the data shown in Figure 2, it is possible to observe that calcein 
was able to bind to the ions released from NPs and that they quenched 
its fluorescence although NPs released Fe3+ ions, for which the calcein 
affinity is reduced if compared to Fe2+ ions. Functionalized particles 
seem to release more than uncoated ones, increasing the quenching at 
the highest concentrations.  
The calcein-injected oocytes have been used, to check if these particles 
were able to cross the membrane and to modify the intracellular 
fluorescence.  
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Figure 4: Mean values of fluorescence intensity (± S.E.M.) of calcein-injected 
oocytes measured at 30 min from the start of the experiments and normalized 
at time 0 values. Controls n=14 – Fe2O3 NPs n=11 – Fe2O3-APTES NPs n=11 
– 3 oocytes batches each – One-way ANOVA test with Bonferroni-Holm post-
hoc correction. 
Data reported in Figure 4 show that particles were not able to quench 
calcein fluorescence (data are means ± S.E.M. - Controls = 95.08% ± 
3.17% - Fe2O3 NPs = 88.57 % ± 3.03% - Fe2O3-APTES NPs = 89.40 % ± 2.70 
%), values reported do not show statistically significant differences. To 
comprehend if the NPs do not cross the membrane or if the signal 
stability can be related to the reduced calcein affinity for the Fe3+ ions 
released from the NPs, the electrophysiological approach was applied 
to investigate the membrane integrity. Monitoring the membrane status 
permits to identify particle effects on the membrane, that could stand 
for a passive permeation that we are not able to detect through the 
fluorescence approach.  
Electrophysiological Approach 
Firstly, membrane capacitance, cell resting potential and membrane 
resistance were evaluated for oocytes exposed to each type of NPs. The 
parameters were measured in control condition (buffered solution pH 
7.6), within 5 min from the start of the exposure and after 20 min, 
according to previous experiments. Values recorded for Fe2O3 NPs are 
reported in Figure 5, those obtained for Fe2O3-APTES NPs in Figure 6.  
Transmembrane currents were measured and plotted in I/V 
relationships to investigate the presence of ion fluxes induced by the 
treatment with NPs. Results are reported in Figure 7 (Fe2O3 NPs) and in 
Figure 8 (Fe2O3-APTES NPs). 
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Figure 5: Membrane capacitance (left), resting potential (center) and 
membrane resistance (right) (means ± S.E.M.) of oocytes in the indicated 
treatment conditions. Controls n=74 – Fe2O3 NPs 5 min n=51 – Fe2O3 NPs 20 
min n=48 – 3 oocytes batches each – One-way ANOVA test with Bonferroni-
Holm post-hoc correction. 
The Fe2O3 NPs were not able to modify any of the membrane 
parameters, neither the one related to endocytosis (capacitance) nor the 
ones relating to membrane integrity and passive permeation (resting 
potential and resistance). None of the time conditions considered 
resulted effective, suggesting the lack of interactions between tested 
NPs and the membrane, and confirming the data collected with calcein 
probe. 
 
Figure 6: Membrane capacitance (left), resting potential (center) and 
membrane resistance (right) (means ± S.E.M.) of oocytes in the indicated 
treatment conditions. Controls n=195 – Fe2O3-APTES NPs 5 min n=81 – 
Fe2O3-APTES NPs 20 min n=86 – 4 oocytes batches each – One-way ANOVA 
test with Bonferroni-Holm post-hoc correction. 
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Likewise, the treatment with Fe2O3-APTES did not modify membrane 
biophysical parameters in any of the condition tested. The coating did 
not modify the NP interactions with the membrane. 
The membrane parameters suggested the absence of membrane 
modification and were validated by the data reported in the I/V 
relationships. 
 
Figure 7: I/V relationships (means ± S.E.M.) obtained from oocytes exposed to 
control condition (buffered solution pH 7.6), Fe2O3 NPs within 5 min and 
Fe2O3 NPs for 20 min. Controls n=74 – Fe2O3 NPs 5 min n=51 – Fe2O3 NPs 
20 min n=48 – 3 oocytes batches each – One-way ANOVA test with 
Bonferroni-Holm post-hoc correction. 
I/V relationships of the Fe2O3 NPs treatments overlap with the control 
one, confirming the lack of interactions with the oocyte membrane. The 
data reported in the I/V curves are limited to +20 mV; at higher voltages 
these oocytes showed the opening of endogenous conductances, 
revealed in all the batches tested (evident already from 0 mV).  
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Figure 8: I/V relationships (means ± S.E.M.) obtained from oocytes exposed to 
control condition (buffered solution pH 7.6), Fe2O3-APTES NPs within 5 min 
and Fe2O3-APTES NPs for 20 min. Controls n=195 – Fe2O3-APTES NPs 5 
min n=81 – Fe2O3-APTES NPs 20 min n=86 – 4 oocytes batches each – One-
way ANOVA test with Bonferroni-Holm post-hoc correction. 
Similarly, Fe2O3-APTES NP treatment was not able to alter in a 
statistically significant way the membrane currents. 
Because Fe2O3 NPs and Fe2O3-APTES NPs were not able to induce 
intracellular calcein quenching, to modify membrane biophysical 
parameters and to alter transmembrane currents, a direct passive 
permeation of these particles can be excluded.  
It is necessary to understand what are the characteristics that impeded 
to these NPs to cross the membrane, since Fe2O3 NPs are rather similar 
to the Fe3O4 NPs which have instead been proved to directly cross the 
membrane. In the case of the APTES functionalized particles, the result 
was even more surprising, since it is known in literature that cationic 
NPs are the most effective in porating the plasma membrane, and the 
coating with APTES gave to these particles 18 nM of free amine group 
per each particle. To this aim, the characterization of these particles in 
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our experimental conditions was performed, to link the particles 
characteristics to their biological behaviour. 
NPs characterization 
As a first step, zeta potential has been determined for both NP types in 
our experimental medium (ND96). After determining the charge, the 
behaviour in suspension was determined through Static Light 
Scattering, since our previous experience and preliminary 
measurements with this kind of particles suggested that this was the 
most appropriate instrument. Results are reported in Figure 9 (zeta 
potentials) and in Figure 10 (Fe2O3 NPs) and Figure 11 (Fe2O3-APTES 
NPs). 
  
Figure 9: zeta potential measurements (n=3 each) obtained with Laser Doppler 
Micro-Electrophoresis for Fe2O3 NPs (mean ± S.D. = 4.07 ± 2.54 mV) and 
Fe2O3-APTES NPs (mean ± S.D. = 5.02 ± 3.85 mV). 
Both particles resulted neutral in our experimental medium; if this was 
somehow expected of the uncoated NPs, since all the previously tested 
metal oxide resulted neutral, it was not for the APTES-coated NPs. The 
most likely hypothesis is that the coating charge (which in water is 
highly positive, around +35 mV) was neutralized by the anions present 
in the medium. The SLS data, according to these zeta potential 
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measurements were expected to show a marked aggregation for both 
types of particles. 
 
Figure 10: Hydrodynamic size distributions of Fe2O3 NPs over 20 min, 
determined by Static Light Scattering (representative experiment). 
From the particles size distributions, it is possible to note that Fe2O3 NPs 
aggregated promptly after their addition in the experimental medium; 
according to our size-dependent particles crossing hypothesis, this 
could be the cause for their ineffectiveness on the membrane. The 
difference with Fe3O4 NPs is also quite evident. 
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Figure 11: Hydrodynamic size distributions of Fe2O3-APTES NPs over 20 
min, determined by Static Light Scattering (representative experiment). 
Interestingly, even though the particles charge is neutral in our 
medium, the coating was successful in stabilizing (at least partially) the 
particles, with a robust population around 100 nm in dimension, which 
decreases for approximately 10 min before aggregating. The 
stabilization probably occurs for steric hindrance, with the particle 
surfaces that are no more able to interact with each other and to 
aggregate; similarly to what seen for BSA coating on Co3O4 and Fe3O4, a 
coating that stabilizes the particles can be able to abolish the effect of the 
NPs on the membrane.  
In this case, when not coated the particles were not effective probably 
because they aggregate very fast becoming too big to interact with the 
membrane. The coating worked to partially stabilize the particles but 
lost positive charge in the experimental medium, resulting 
subsequently ineffective in promoting passive permeation of the 
particles; the size effects reported previously is likely to happen with 
particles with unmodified surface, while coating (covalent or non-
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covalent) dramatically changes the interactions with the membranes of 
the surface-modified particles. 
Conclusions 
Fe2O3 NPs resulted unable to modify intracellular iron concentration 
and membrane biophysical parameters, probably because their 
aggregation rate in the experimental medium is too fast to let them 
interact with the membrane. Coating these particles with APTES 
partially stabilizes them, but the experimental medium utilized masked 
the particles positive charge that could promote membrane crossing. 
These particles are therefore inert in our experimental conditions. 
New pathways will be used to raise the internalization of these 
magnetic particles; in particular, a targeted endocytosis approach is 
currently under development.  
Validating this approach will benefit of the use of the Xenopus laevis 
oocytes transfected with specific proteins, that will provide a platform 
to test differently functionalized metal particles, and to determine their 
probability of internalization through molecular and 
electrophysiological approaches. 
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Chapter 6 
During the three years of my Ph.D., I focused my research activity on 
the interactions between metal NPs and cell membrane, to investigate 
about the possibility that selected NPs are able to cross directly the 
membrane bypassing the classical endocytotic routes. This hypothesis 
has been tested and studied in Xenopus laevis oocytes. These cells have a 
reduced endocytotic activity, which makes them suitable to focus on 
alternative internalization mechanisms. Furthermore, Xenopus oocytes 
can be cultured for days in saline solution and this enables the 
researcher to avoid the biomolecule corona usually formed by serum 
protein around nanomaterials in biological fluids. This is an advantage 
because protein corona deeply modifies the interactions with the cells. 
The second aim of my research work was to find a correlation between 
the effects of the various NPs tested and their physico-chemical 
properties, to identify key parameters leading to direct membrane 
crossing. 
In Chapter 2, the evidences of a direct crossing of the membrane were 
reported for Co3O4 NPs. These NPs induced an intracellular Co2+ 
increase, but neither Co NPs nor Co3O4@BSA NPs had the same effect, 
highlighting existing differences between NPs and that the presence of 
a biomolecular corona could influence NP-membrane interactions. All 
the cobalt-based NPs tested were able to release ionic metal in 
experimental condition. Cell integrity was not compromised after 30 
min of Co3O4 treatment and an endocytosis inhibitor had no effect on 
intracellular Co2+ concentration increase. 
The application of an electrophysiological technique to study the direct 
membrane crossing of metal NPs is the core of Chapter 3, with the focus 
on the alteration of membrane biophysical characteristics. Iron-based 
NPs were used for this study.  
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Starting with the fluorescence probe experiments, it was assessed that 
Fe3O4 could induce an increase in intracellular Fe2+, while neither Fe NPs 
nor Fe3O4@BSA NPs were able to do the same. Voltage clamp 
experiments on Xenopus oocytes membrane monitored the membrane 
status during the treatment with NPs. Membrane biophysical 
parameters were significantly modified by Fe3O4 NPs treatment only in 
oocytes tested within 5 min from the start of the incubation with NPs. 
Membrane resistance and resting potential were significantly 
decreased, while membrane capacitance (which is a parameter that can 
vary in the presence of endocytosis) was not. Treatment with Fe NPs 
and with Fe3O4@BSA NPs confirmed the absence of effects of these NPs 
on the membrane, as suggested by fluorescence probe experiments.  
Analysing NPs physico-chemical characteristics a difference was 
highlighted in the particles size distributions, with a submicron 
population present only in the Fe3O4 NPs distribution, which is stable 
for 5 min before aggregation. BSA addition stabilized Fe3O4 NPs for 30 
min, but the surface coating was most likely preventing the physical 
interaction occurring with the membrane, suggesting that the particles 
must maintain a submicron size and a bare surface to interact with cell 
membrane and cross it. After 5 min the particles aggregated and 
membrane resealed. The dependency of the direct crossing from the 5 
min population was proven by treating oocytes with aggregated Fe3O4 
NPs; treatment with these NPs was not effective neither on the 
intracellular calcein nor on the electrophysiological parameters. 
In Chapter 4, the focus was monitoring biophysical membrane 
parameters for detecting interactions occurring in the presence of Co3O4, 
Co, Ni and NiO NPs.  
Co3O4 NPs are effective in causing the membrane parameter 
modifications. Oocytes were able to reseal after 5 min, which explains 
why testing cells after 30 min as reported in the paper in Chapter 2 
showed only non-significant difference in membrane currents. The 
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direct cross it is possible only in the presence of 5 min submicron 
population. Co NPs and Co3O4@BSA NPs were not able to modify the 
biophysical properties of the membrane, substantially confirming the 
fluorescence data reported in Chapter 2. Co NPs were non-effective 
probably because their aggregation is too rapid, as shown by their 
hydrodynamic size distributions; Co3O4@BSA NPs were stabilized (in 
terms of submicron population), but this surface modification could 
possibly prevent particles from reacting not only with each other (which 
is the actual stabilization we saw) but also against the cellular 
membrane.  
Ni-based particles resulted non-effective with none of the techniques we 
utilized, neither in fluorescence nor in electrophysiology, either the 
metallic form or the oxide form. Their z-potentials are neutral in the 
experimental medium. Size distributions showed Ni NPs aggregate just 
after particles were added in the medium, while NiO NPs retained a 
submicron population for the whole experiment duration. a difference 
was highlighted comparing the hydrodynamic size distributions of 
Co3O4 and NiO NPs, where it is possible to see that Co3O4 submicron 
population was composed of smaller NPs than the NiO NPs one 
(indicatively smaller than 200 nm). This “below-200 nm” population 
could be the one responsible for particles effect. 
As a final step, Fe2O3 NPs were tested; these particles are already 
applied in many fields, are considered inert and possess many 
interesting properties related to their magnetic susceptibility and their 
superparamagnetism. Bypassing endocytosis and gaining direct access 
to the cytoplasm would increase the applications of these particles. 
Furthermore, it is possible to functionalize these particles with APTES, 
an organosilane which provides the particles with positively charged 
amine residues. 
Fe2O3 NPs and Fe2O3-APTES NPs failed to induce any modifications in 
intracellular calcein fluorescence and in membrane biophysical 
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parameters and membrane currents. The hydrodynamic size 
distributions showed that Fe2O3 NPs promptly aggregated when added 
to the experimental medium. Characterization demonstrated that 
particles charge resulted close to neutrality. Surprisingly, even though 
the covalent surface modification was successful in the experimental 
medium the stabilization of Fe2O3-APTES NPs was only partial and z-
potential resulted neutral. The surface modification is thus able to 
stabilize the particles and to reduce their dimension, but the ability to 
direct cross the membranes were not changed if compared to bare NPs, 
pointing out a key role also for the surface coating of the NPs in 
dictating passive membrane crossing. 
In this Ph.D. thesis several kinds of metal-based NPs were tested in 
Xenopus laevis oocytes and the results can be categorized as follows: 
 
 The metallic NPs tested (Co, Fe, Ni) dissolve more than their 
oxide counterparts; however, in a medium with moderate 
osmolarity as the Xenopus laevis culture solution, they are 
unstable in suspension and their aggregation rate is fast. All 
these particles are not able to induce modifications in membrane 
biophysical parameters and in intracellular metal concentration, 
thereby excluding a direct membrane crossing mechanism for 
their internalization. 
 The metal oxide NPs which retain a population below 200 nm 
(Fe3O4, Co3O4) in suspension in experimental medium induced 
significant modifications in membrane biophysical parameters 
and in intracellular metal concentration. The effects are recorded 
only when the population of NPs smaller than 200 nm is present, 
namely only within 5 min from the particles addition to the 
medium; after this time range, effects on membrane become 
milder until they disappear, stating the complete fast recovery 
of the membrane.  
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 Aggregated particles are able not to cross the membrane, 
confirming the role of the size in this kind of interactions. 
 The metal oxide NPs that never go below 200 nm (NiO, Fe2O3) 
in suspension in the experimental medium do not cross the 
membrane and do not modify neither intracellular metal 
concentration nor membrane biophysical parameters. 
 The surface coating modify particles behavior in suspension in 
the experimental medium. The non-covalent coating by BSA 
stabilized the 200 nm population for Co3O4 and Fe3O4 NPs but 
abolished the modifications in intracellular metal concentration 
and in membrane biophysical parameters. The covalent coating 
by APTES of Fe2O3 NPs partially stabilized particles around 100 
nm but failed to induce membrane crossing.  
 The role of particle surface is thus crucial to achieve direct 
membrane crossing. 
Direct membrane crossing it is indeed a mechanism that has been 
reported in few studies, but its implications may be revolutionary. 
Many of the studies conducted nowadays rely on models, both in silico 
as well as in vitro, that are limited in replicating the biological 
complexity of the cells. Using voltage clamp and fluorescent probe on 
Xenopus Laevis oocytes may lay the foundation for an innovative 
screening platform for investigating nanocompounds which could 
potentially access cytoplasm directly, allowing to study the 
internalization and the effects on membrane. Xenopus laevis oocytes are 
easy to collect, maintain and prepare. They are flexible and adaptable to 
different culture conditions, allowing to study interactions in controlled 
environment.  
Moreover, Xenopus laevis oocytes can also be a useful tool to study and 
optimize targeted internalization. Their historical use as heterologous 
expression system is well known, selectively express target proteins to 
~ 168 ~ 
 
study specific internalization pathways of new modified nanoparticles 
will be one of the new goals for the therapeutic use of nanomaterial. 
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